FILTRI
Pembrolizumab in MMR-Proficient Metastatic Colorectal Cancer Pharmacologically Primed to Trigger Hypermutation Status
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03519412
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Grande Ospedale Metropolitano Niguarda, Milano, Italy
Istituto Europeo di Oncologia, Milano, Italy
Istituto Nazionale Tumori di Milano, Milano, Italy
Istituto Clinico Humanitas, Rozzano, Italy
Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal Cancer
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04310176
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Temozolomide and Irinotecan in Patients With MGMT Silenced Colorectal Cancer After Adjuvant Chemotherapy
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05031975
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04689347
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1
Retrospective Study on the Use of Immunotherapy in Patients With MSI-H Metastatic Colorectal Cancer
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04612309
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients With LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04854213
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Non Disponibile
Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal Cancer
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04397601
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
SSD-Terapie Innovative Metastasi Addominali, Dipartimento di Oncologia Addominale, Istituto Nazionale Tumori di Napoli, IRCCS "G. Pascale"., Naples, Italy
Adjuvant Durvalumab Plus Regorafenib vs Untreated Control in Stage IV Colorectal Cancer Patients With no Evidence of Disease (NED): VIVA Trial
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05382741
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03874026
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
A Phase Ib/IIa Study of CR6086 in Combination With Balstilimab in pMMR-MSS Metastatic Colorectal Cancer Patients
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05205330
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1, Fase 2
Second Look Laparoscopy in Colorectal Cancer
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT01628211
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento Entero-proctologico, Napoli, Italy
PAnitumumab REchallenge Followed by REgorafenib Versus the Reverse Sequence
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04787341
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Colorectal Cancer Surgery
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04037787
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Non Disponibile
Early Discharge After Robotic Colorectal Surgery (eRCS): a Prospective Observational Study
- Stato: Non ancora in arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05408182
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Modulatory Effects of Active Drugs on the Endocannabinoid System on Spontaneous and Induced Contractility of the Colon
- Stato: In arruolamento
- Fascia d'età: Bambini, AdultiAnziani
- Codice Sperimentazione: NCT05760404
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Early Detection of Relapses in Stage IV Colorectal Cancer Patients
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04232891
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Fondazione del Piemonte per l' Oncologia - IRCCS Candiolo, Candiolo, Torino, Italy
Ospedale Mauriziano, Torino, Italy
Trifluridine/Tipiracil in Combination With Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients.
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04564898
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1, Fase 2
Fondazione IRCCS Istituto Nazionale Tumori, Milano, MI, Italy
Azienda Ospedaliero Universitaria Pisana, Pisa, PI, Italy
Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT02919644
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
UO Immunoterapia e Laboratorio TCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) S.r.l IRCCS, Meldola, FC, Italy
CRO-IRCCS Aviano, Aviano, Italy
Pancreas Resection for Colorectal Metastasis: Retrospective Study
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05714475
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Colorectal Carcinoma. CHECK Study.
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03914820
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 3
IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy
ASP PO Sant'Elia, Caltanissetta, Italy
AO Santa Croce e Carle, Cuneo, Italy
ULLS1 1 Dolomiti - Ospedale di Feltre, Feltre, Italy
Ospedale dell Angelo, Mestre, Italy
ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
Policlinico di Milano, Milano, Italy
A.O.R.N. A. Cardarelli, Napoli, Italy
Azienda Ospedaliera Universitaria Federico II, Napoli, Italy
Ospedale Evangelico Betania, Napoli, Italy
AOU Policlinico Paolo Giaccone, Palermo, Italy
Azienda Ospedaliera S. Camillo Forlanini, Roma, Italy
Fondazione Policlinico Universitario A. Gemelli, Roma, Italy
Fondazione Policlinico Universitario A. Gemelli, Roma, Italy
Policlinico Universitario Agostino Gemelli Irccs Universita' Cattolica Del Sacro Cuore, Roma, Italy
IRCCS Policlinico San Donato, San Donato Milanese, Italy
IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05328908
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 3
Local Institution - 0091, Genova, GE, Italy
Local Institution - 0148, Padova, PD, Italy
Local Institution - 0060, Catania, Italy
Local Institution - 0046, Milano, Italy
Local Institution - 0045, Milan, Italy
Local Institution - 0115, Napoli, Italy
Local Institution - 0061, Napoli, Italy
Local Institution - 0136, Padova, Italy
Local Institution - 0059, Reggio Emilia, Italy
Highlands Oncology Group - Springdale, Springdale, Arkansas, United States
City Of Hope, Duarte, California, United States
USC Norris Comprehensive Cancer Center, Los Angeles, California, United States
Eastern Connecticut Hematology and Oncology (ECHO), Norwich, Connecticut, United States
Baptist Hospital of Miami, Miami, Florida, United States
Northside Hospital - Atlanta, Atlanta, Georgia, United States
St. Luke's Cancer Institute - Boise, Boise, Idaho, United States
Rush University Medical Center, Chicago, Illinois, United States
Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana, United States
Massachusetts General Hospital,, Boston, Massachusetts, United States
University of Michigan - Rogel Cancer Center, Ann Arbor, Michigan, United States
Mayo Clinic in Arizona - Phoenix, Rochester, Minnesota, United States
Astera Cancer Care, East Brunswick, New Jersey, United States
Duke University Medical Center, Durham, North Carolina, United States
Good Samaritan Hospital, Cincinnati, Ohio, United States
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C, Columbus, Ohio, United States
The James Cancer Hospital, Columbus, Ohio, United States
Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Thomas Jefferson University - Clinical Trials Office-Medical Oncology, Philadelphia, Pennsylvania, United States
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Charleston Hematology Oncology Associates (CHOA), Charleston, South Carolina, United States
Sanford Research, Sioux Falls, South Dakota, United States
Tennessee Oncology, Nashville, Tennessee, United States
The Center For Cancer and Blood Disorders, Fort Worth, Texas, United States
Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia, United States
University of Wisconsin-Madison - Wisconsin Institutes for Medical Research (WIMR), Madison, Wisconsin, United States
Local Institution - 0022, Ciudad Autonoma Buenos Aires, Buenos Aires, Argentina
Local Institution - 0024, Ciudad Autónoma Buenos Aires, Buenos Aires, Argentina
Local Institution - 0023, Viedma, RIO Negro, Argentina
Local Institution - 0028, Buenos Aires, Argentina
Local Institution - 0026, Buenos Aires, Argentina
Local Institution - 0098, Wagga Wagga, New South Wales, Australia
Local Institution - 0114, Westmead, New South Wales, Australia
Local Institution - 0001, Greenslopes Qld, Queensland, Australia
Local Institution - 0002, Woodville South, South Australia, Australia
Local Institution - 0010, Clayton, Victoria, Australia
Local Institution - 0021, Melbourne, Victoria, Australia
Local Institution - 0027, Perth, Western Australia, Australia
Local Institution - 0030, Graz, Austria
Local Institution - 0078, Klagenfurt, Austria
Local Institution - 0131, Salzburg, Austria
Local Institution - 0068, Gent, VOV, Belgium
Local Institution - 0133, Liège, WLG, Belgium
Local Institution - 0070, Edegem, Belgium
Local Institution - 0120, Leuven, Belgium
Local Institution - 0062, Woluwé-Saint-Lambert, Belgium
Local Institution - 0003, Edmonton, Alberta, Canada
Local Institution - 0014, Ottawa, Ontario, Canada
Local Institution - 0007, Toronto, Ontario, Canada
Local Institution - 0019, Montreal, Quebec, Canada
Local Institution - 0104, Montreal, Quebec, Canada
Local Institution - 0004, Sherbrooke, Quebec, Canada
Local Institution - 0015, Santiago, RM, Chile
Local Institution - 0033, Santiago, RM, Chile
Local Institution - 0122, Beijing, Beijing, China
Local Institution - 0134, Chongqing, Chongqing, China
Local Institution - 0151, Guangzhou, Guangdong, China
Local Institution - 0126, Wuhan, Hubei, China
Local Institution - 0125, Changsha, Hunan, China
Local Institution - 0138, Changsha, Hunan, China
Local Institution - 0146, Huaian, Jiangsu, China
Local Institution - 0149, Shenyang Shi, Liaoning, China
Local Institution - 0142, Jinan, Shandong, China
Local Institution - 0153, Shanghai, Shanghai, China
Local Institution - 0141, Taiyuan, Shanxi, China
Local Institution - 0144, Chengdu, Sichuan, China
Local Institution - 0152, Xian, SN, China
Local Institution - 0150, Tianjin, Tianjin, China
Local Institution - 0157, Guangzhou, China
Local Institution - 0139, Hangzhou, China
Local Institution - 0156, Harbin, China
Local Institution - 0143, Nanjing City, China
Local Institution - 0155, Shanghai, China
Local Institution - 0123, Ostrava, Poruba, Czechia
Local Institution - 0099, Horovice, Czechia
Local Institution - 0016, Hradec Králové, Czechia
Local Institution - 0064, Praha 5, Czechia
Local Institution - 0100, Uherske Hradiste - Sady, Czechia
Local Institution - 0066, Bordeaux, France
Local Institution - 0017, Caen, France
Local Institution - 0090, Dijon, France
Local Institution - 0020, Levallois-Perret, France
Local Institution - 0036, Lyon, France
Local Institution - 0089, Paris, France
Local Institution - 0039, Suresnes, France
Local Institution - 0055, Berlin, BE, Germany
Local Institution - 0053, Wuerzburg, BY, Germany
Local Institution - 0041, Frankfurt A. Main, HE, Germany
Local Institution - 0101, Essen, Northwest, Germany
Local Institution - 0040, Hamburg, Germany
Local Institution - 0054, Mannheim, Germany
Local Institution - 0034, Muenchen, Germany
Local Institution - 0056, Reutlingen, Germany
Local Institution - 0107, Chiba-shi, Chiba, Japan
Local Institution - 0118, Matsuyama-shi, Ehime, Japan
Local Institution - 0088, Sapporo-shi, Hokkaido, Japan
Local Institution - 0086, Kawasaki-shi, Kanagawa, Japan
Local Institution - 0124, Yokohama-shi, Kanagawa, Japan
Local Institution - 0083, Suita-shi, Osaka, Japan
Local Institution - 0105, Hidaka-Shi, Saitama, Japan
Local Institution - 0119, Kitaadachi-gun, Saitama, Japan
Local Institution - 0085, Sunto-gun, Shizuoka, Japan
Local Institution - 0103, Chuo-Ku, Japan
Local Institution - 0084, Kashiwa-Shi, Japan
Local Institution - 0108, Koto-Ku, Japan
Local Institution - 0110, Osaka, Japan
Local Institution - 0073, Goyang-si, Gyeonggi-do, Korea, Republic of
Local Institution - 0129, Seongnamsi Bundanggu, Korea, Republic of
Local Institution - 0072, Seoul, Korea, Republic of
Local Institution - 0092, Seoul, Korea, Republic of
Local Institution - 0075, Seoul, Korea, Republic of
Local Institution - 0074, Seoul, Korea, Republic of
Local Institution - 0063, Utrecht, UT, Netherlands
Local Institution - 0050, Amsterdam, Netherlands
Local Institution - 0051, Warsaw, MZ, Poland
Local Institution - 0037, Warszawa, Pl-mz, Poland
Local Institution - 0018, Krakow, Poland
Local Institution - 0052, Warszawa, Poland
Local Institution - 0106, San Juan, Puerto Rico
Local Institution - 0109, Singapore, Singapore
Local Institution - 0087, Singapore, Singapore
Local Institution - 0093, Barcelona, B, Spain
Local Institution - 0102, Madrid, M, Spain
Local Institution - 0116, Zaragoza, Z, Spain
Local Institution - 0080, Barcelona, Spain
Local Institution - 0029, Barcelona, Spain
Local Institution - 0112, La Coruña, Spain
Local Institution - 0113, Madrid, Spain
Local Institution - 0035, Sevilla, Spain
Local Institution - 0038, Stockholm, AB, Sweden
Local Institution - 0067, Goteborg, Sweden
Local Institution - 0094, Malmö, Sweden
Local Institution - 0135, Stockholm, Sweden
Local Institution - 0058, Uppsala, Sweden
Local Institution - 0057, Aarau, AG, Switzerland
Local Institution - 0069, Bern, Switzerland
Local Institution - 0111, Kaohsiung, KHH, Taiwan
Local Institution - 0128, Changhua City, Changhua, Taiwan
Local Institution - 0076, Tainan, Taiwan
Local Institution - 0077, Tainan, Taiwan
Local Institution - 0121, Taipei City, Taiwan
Effects of COVID-19 Pandemic on the Outcomes of Colorectal Cancer
- Stato: In arruolamento
- Fascia d'età: Bambini, AdultiAnziani
- Codice Sperimentazione: NCT04712292
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Rho Memorial Hospital, Rho, Milan, Italy
Humanitas Research Center, Rozzano, Milan, Italy
AOU Policlinico di Bari "M. Rubino", Bari, Italy
Policlinico di Bari, Bari, Italy
Humanitas Gavazzeni Hospital, Bergamo, Italy
Policlinico San Marco, Bergamo, Italy
Maggiore Hospital, Bologna, Italy
Fondazione Poliambulanza, Brescia, Italy
Spedali Civili, Brescia, Italy
Spedali Civili, Brescia, Italy
Santissima Trinità Hospital, Cagliari, Italy
Vittorio Emanuele III Hospital, Carate Brianza, Italy
San Paolo Hospital, Civitavecchia, Italy
AUSL Romagna Ravenna-Faenza, Faenza, Italy
San Giovanni di Dio Hospital, Firenze, Italy
Gardone Val Trompia Hospital, Gardone Val Trompia, Italy
ASST FBF Sacco Hospital, Milan, Italy
San Raffaele Hospital, Milan, Italy
ASST Santi Paolo e Carlo Hospital, Milan, Italy
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Milano, Milan, Italy
Istituto Nazionale dei Tumori, Milan, Italy
Mirano Hospital, Mirano, Italy
AORN Cardarelli, Napoli, Italy
Università della Campania Luigi Vanvitelli, Napoli, Italy
Padova University Hospital, Padova, Italy
Veneto Institute of Oncology IOV-IRCCS, Padova, Italy
Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
AOU Parma, Parma, Italy
San Matteo Hospital, Pavia, Italy
Pederzoli Hospital, Peschiera Del Garda, Italy
Azienda Sanitaria Fiuli Occidentale, Pordenone, Italy
Ceccarini Hospital, Riccione, Italy
Infermi Hospital, Rimini, Italy
Campus Biomedico, Roma, Italy
Fondazione Policlinico Roma Tor Vergata, Roma, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy
San Filippo Neri Hospital, Roma, Italy
Sant'Eugenio Hospital, Roma, Italy
UOSD Tor Vergata, Roma, Italy
AOU Sassari, Sassari, Italy
Regional Hospital Treviso, Treviso, Italy
University Hospital of Trieste, Trieste, Italy
AOU Città della Salute e della Scienza, Turin, Italy
Mauriziano Hospital, Turin, Italy
ASST Vimercate, Vimercate, Italy
Videocapsule Endoscopy in Lynch Syndrome
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05704010
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Non Disponibile
San Raffaele Scientific Institute, Gastroenterology and Gastrointestinal Endoscopy Unit, Milan, Lombardia, Italy
Neutrophil-to-Lymphocite Ratio (NLR) and C-reactive Protein (CRP) as New Markers in Diagnosis and Prediction of Colorectal Cancer
- Stato: Arruolamento su invito
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05129046
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
IRCCS - Ca' Granda - Fondazione Policlinico di Milano, Milan, Italy
San Raffaele Hospital, Milan, Italy
Città della Salute - Chirurgia Generale d'Urgenza e PS, Turin, Italy
LIVACOR Trial: Minimally Invasive LIVer And Simultaneous COlorectal Resection
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05138094
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Non Disponibile
Federico II University Hospital, Naples, Calabria, Italy
Azienda USL di Bologna, Bologna, Emilia-Romagna, Italy
Azienda Ospedaliero-Universitaria di Modena, Modena, Emilia-Romagna, Italy
Parma University Hospital, Parma, Emilia-Romagna, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Lazio, Italy
Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Lombardy, Italy
San Raffaele University Hospital, Milan, Lombardy, Italy
Ospedali Riuniti, Ancona, Marche, Italy
Mauriziano Umberto I Hospital, Turin, Piemonte, Italy
University Hospital Padova, Padova, Veneto, Italy
Ziekenhuis Oost-Limburg, Genk, Limburg, Belgium
General Hospital Groeninge, Kortrijk, West Flanders, Belgium
Antoine-Béclère Hospital, Paris, Île-de-France, France
Klinikum Saarbrücken, Klinik für Allgemein-, Viszeral- und Thoraxchirurgie, Chirurgische Onkologie, Saarbrücken, Saarland, Germany
Centre Hospitalier du Luxembourg, Luxembourg, Luxembourg
Maastricht University Medical Center, Maastricht, Limburg, Netherlands
Amsterdam UMC, Amsterdam, Noord-Holland, Netherlands
Oslo University Hospital, Oslo, Østlandet, Norway
Moscow Clinical Scientific Center, Moscow, Moscow Oblast, Russian Federation
Hospital del Mar, Barcelona, Catalonia, Spain
University of Navarrra Hospital (Clinica Universitaria), Pamplona, Navarre, Spain
Manchester University NHS Foundation Trust, Manchester, North West England, United Kingdom
Newcastle-upon-Tyne Hospitals NHS Trust, Newcastle, Northeast England, United Kingdom
Liverpool University Hospitals NHS Foundation Trust, Liverpool, Northwest England, United Kingdom
University Hospital Southampton NHS Foundation Trust, Southampton, South East England, United Kingdom
King's College Hospital NHS Trust, London, Southeast England, United Kingdom
University Hospital Plymouth NHS Trust, Plymouth, Southwest England, United Kingdom
University Hospital Birmingham NHS Foundation Trust, Birmingham, West Midlands, United Kingdom
Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04776655
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 3
Ospedale San Salvatore, Coppito, L'Aquila, Italy
Ospedale Civile di Guastalla, Guastalla, Reggio Emilia, Italy
Azienda ULSS 3 Serenissima, Mirano, VE, Italy
AUSL/IRCCS di Reggio Emilia, Reggio Emilia, Italy
Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03806426
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 3
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03659448
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 3
Fondazione IRCCS Policlinico San Matteo, Pavia, Lombardia, Italy
Moores Cancer Center - UCSD Health, La Jolla, California, United States
Cleveland Clinic Florida, Weston, Florida, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
University of Massachusetts, Worcester, Massachusetts, United States
Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States
Universitätsmedizin Göttingen, Klinik für Allgemein- Viszeral- und Kinderchirurgie, Göttingen, Germany
Catharina Ziekenhuis Eindhoven, Eindhoven, Netherlands
Leiden University Medical Center, Leiden, Netherlands
Erasmus MC, Rotterdam, Netherlands
Advanced Therapies for Liver Metastases
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04622423
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Low Tie Versus High Tie of the Inferior Mesenteric Vein During Colorectal Cancer Surgery: A Randomized Clinical Trial
- Stato: In arruolamento
- Fascia d'età: Bambini, AdultiAnziani
- Codice Sperimentazione: NCT05411783
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Non Disponibile
REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05396807
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Non Disponibile
Scienze della Salute Università degli Studi di Firenze, Firenze, Italy
Unità Oncologia Medica Dipartimento di Discipline Chirurgiche, Oncologiche e Stomatologiche, Palermo, Italy
Medical Oncology Unit, Department of Oncohematology, Policlinico Tor Vergata, Roma, Italy
"Grigore T. Popa" University of Medicine and Pharmacy of Iași, Iaşi, Iași, Romania
Regional Institute of Oncology, Iaşi, Iași, Romania
Hospital General Universitario Santa Lucía, Cartagena, Murcia, Spain
A Retrospective Protocol Empowering Precision Research in Colorectal Cancer (ALFAOMEGA-RETRÒ)
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05101382
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Ospedale Policlinico San Martino, Genova, GE, Italy
Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, MI, Italy
Niguarda Cancer Center - ASST Grande Ospedale Metropolitano Niguarda, Milan, MI, Italy
Istituto Oncologico Veneto (IOV), Padua, PD, Italy
Istituto di Candiolo - IRCCS, Candiolo, TO, Italy
Azienda Ospedaliero Universitaria San Luigi Gonzaga, Orbassano, TO, Italy
Azienda Ospedaliera Ordine Mauriziano, Torino, TO, Italy
Hospital del Mar - Parc de Salut Mar, Barcelona, Spain
Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
INCLIVA - Instituto de Investigatión Sanitaria, Valencia, Spain
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03485209
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Seconda Università degli Studi di Napoli, AOU, Napoli, Other, Italy
Azienda USL Toscana Centro, Pistoia, Other, Italy
Oncologia Medica, Ospedale Civile S. Maria delle Croci, Ravenna, Other, Italy
PU Campus Bio-medico di Roma, Roma, Other, Italy
University of California Davis, Sacramento, California, United States
Stanford Cancer Center / Blood and Marrow Transplant Program, San Jose, California, United States
Poudre Valley Health System (PVHS), Fort Collins, Colorado, United States
Yale Cancer Center, New Haven, Connecticut, United States
Shands Cancer Center / University of Florida, Gainesville, Florida, United States
University Cancer & Blood Center, LLC, Athens, Georgia, United States
Winship Cancer Institute / Emory University School of Medicine, Atlanta, Georgia, United States
Ingalls Cancer Care / Ingalls Memorial Hospital, Harvey, Illinois, United States
Community Health Network, Indianapolis, Indiana, United States
University of Kansas Cancer Center, Westwood, Kansas, United States
Norton Cancer Institute, Louisville, Kentucky, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
HealthPartners Institute, Saint Louis Park, Minnesota, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Weill Cornell Medicine, New York, New York, United States
UNC Lineberger Comprehensive Cancer Center / University of North Carolina, Chapel Hill, North Carolina, United States
Wake Forest Baptist Medical Center / Wake Forest University, Winston-Salem, North Carolina, United States
Oregon Health and Science University, Portland, Oregon, United States
University of Pennsylvania / Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States
Rhode Island Hospital, Providence, Rhode Island, United States
Texas Oncology - Fort Worth, Dallas, Texas, United States
MD Anderson Cancer Center / University of Texas, Houston, Texas, United States
Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas, United States
Renovatio Clinical, The Woodlands, Texas, United States
University of Virginia, Charlottesville, Virginia, United States
University of Alberta / Cross Cancer Institute, Edmonton, Alberta, Canada
Hospitalier Jean Minjoz, Besancon, Other, France
Centre léon Bérard, LYON cedex 08, Other, France
APHM Hôpital Nord, Marseille Cedex 20, Other, France
Hopital Prive du Confluent, Nantes Cedex 2, Other, France
Hopital Foch, Suresnes, Other, France
Ruhr-Uni. Bochum, St. Josef-Hospital, Bochum, Other, Germany
Universitätsklinikum Halle-Universitätsklinik und Poliklinik, Halle, Other, Germany
Vincentius-Diakonissen-Kliniken gAG, Karlsruhe, Other, Germany
Hospital Universitari Germans Trias i Pujol, Badalona, Other, Spain
Hospital Quirónsalud Barcelona Instituto Oncologico Baselga, Barcelona, Other, Spain
Hospital Universitario Vall d'Hebron, Barcelona, Other, Spain
Hospital Universitario Ramon y Cajal, Madrid, Other, Spain
HM Centro Integral Oncologico Clara Campal, Madrid, Other, Spain
Althaia Xarxa Assistencial Manresa, Manresa, Other, Spain
Guys and St Thomas Hospital, London, Other, United Kingdom
CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05291156
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
A.O.U. Ospedali Riuniti, Ancona, Italy
A.O. San Giuseppe Moscati, Avellino, Italy
Centro di Riferimento Oncologico (C.R.O.), Aviano, Italy
Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy
P.O. Antonio Perrino, Brindisi, Italy
Ospedale IRCCS 'Saverio de Bellis', Castellana Grotte, Italy
A.R.N.A.S. Garibaldi - P.O. GaribaldiNesima, Catania, Italy
A.O.U. Careggi, Firenze, Italy
Ospedale Policlinico San Martino IRCCS per l'Oncologia, Genova, Italy
P.O. 'Vito Fazzi', Lecce, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
Istituto Europeo di Oncologia, Milano, Italy
A.O.U dell'Università degli Studi della Campania "Luigi Vanvitelli", Napoli, Italy
IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale", Napoli, Italy
A.O.U. Policlinico 'P. Giaccone', Palermo, Italy
ARNAS Civico - Di Cristina-Benfratelli - P. O. 'Civico e Benfratelli', Palermo, Italy
A.S.P. Ragusa - Ospedale Maria Paternò Arezzo, Ragusa, Italy
Azienda USL IRCCS di Reggio Emilia, Reggio Emilia, Italy
Fondazione Policlinico Universitario 'Agostino Gemelli' IRCCS, Roma, Italy
Fondazione IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
Ospedale San Giuseppe Moscati, Taranto, Italy
A.O. Ordine Mauriziano, Torino, Italy
A.O. 'Pia Fondazione Cardinale G.Panico', Tricase, Italy
A.O.U. Integrata di Verona - Policlinico 'Giambattista Rossi', Verona, Italy
ALFAOMEGA Master Observational Trial
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04120935
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, MI, Italy
Istituto Europeo di Oncologia (IEO), Milan, Mi, Italy
Niguarda Cancer Center - ASST Grande Ospedale Metropolitano Niguarda, Milan, MI, Italy
Istituto Oncologico Veneto (IOV), Padova, PD, Italy
Istituto di Candiolo - IRCCS, Candiolo, Torino, Italy
Azienda Ospedaliero Universitaria San Luigi Gonzaga, Orbassano, Torino, Italy
ASL di Biella - Ospedale degli Infermi, Biella, Italy
Ospedale Policlinico San Martino, Genova, Italy
Ospedale Santa Maria della Misericordia, Perugia, Italy
Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
AUSL della Romagna - Ospedale Santa Maria delle Croci, Ravenna, Italy
Azienda Ospedaliera Ordine Mauriziano, Torino, Italy
Hospital del Mar - Parc de Salut Mar, Barcelona, Spain
Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Hospital de Sant Joan Despí Moises Broggi, Barcelona, Spain
INCLIVA - Instituto de Investigatión Sanitaria, Valencia, Spain
Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04793958
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 3
Research Site, Lido Di Camaiore, Lucca, Italy
Research Site, Candiolo, Torino, Italy
Research Site, Avellino, Italy
Research Site, Biella, Italy
Research Site, Cagliari, Italy
Research Site, Milano, Italy
Research Site, Milan, Italy
Research Site, Naples, Italy
Research Site, Padova, Italy
Research Site, Pisa, Italy
Research Site, Reggio Emilia, Italy
Research Site, Roma, Italy
Research Site, Turin, Italy
Research Site, Birmingham, Alabama, United States
Research Site, Gilbert, Arizona, United States
Research Site, Goodyear, Arizona, United States
Research Site, Phoenix, Arizona, United States
Research Site, Springdale, Arkansas, United States
Research Site, Bakersfield, California, United States
Research Site, Clovis, California, United States
Research Site, Fullerton, California, United States
Research Site, Los Angeles, California, United States
Research Site, Los Angeles, California, United States
Research Site, Redlands, California, United States
Research Site, San Diego, California, United States
Research Site, San Francisco, California, United States
Research Site, Sylmar, California, United States
Research Site, Torrance, California, United States
Research Site, Whittier, California, United States
Research Site, Aurora, Colorado, United States
Research Site, Denver, Colorado, United States
Research Site, Norwich, Connecticut, United States
Research Site, Fort Myers, Florida, United States
Research Site, Jacksonville, Florida, United States
Research Site, Miami, Florida, United States
Research Site, Ocala, Florida, United States
Research Site, Orlando, Florida, United States
Research Site, Orlando, Florida, United States
Research Site, Saint Petersburg, Florida, United States
Research Site, Saint Petersburg, Florida, United States
Research Site, Tallahassee, Florida, United States
Research Site, West Palm Beach, Florida, United States
Research Site, Weston, Florida, United States
Research Site, Atlanta, Georgia, United States
Research Site, Newnan, Georgia, United States
Research Site, Naperville, Illinois, United States
Research Site, Zion, Illinois, United States
Research Site, Iowa City, Iowa, United States
Research Site, Baton Rouge, Louisiana, United States
Research Site, Baltimore, Maryland, United States
Research Site, Boston, Massachusetts, United States
Research Site, Detroit, Michigan, United States
Research Site, Minneapolis, Minnesota, United States
Research Site, Rochester, Minnesota, United States
Research Site, Saint Paul, Minnesota, United States
Research Site, Springfield, Missouri, United States
Research Site, Lincoln, Nebraska, United States
Research Site, Las Vegas, Nevada, United States
Research Site, Belleville, New Jersey, United States
Research Site, Florham Park, New Jersey, United States
Research Site, New Brunswick, New Jersey, United States
Research Site, Somerset, New Jersey, United States
Research Site, New York, New York, United States
Research Site, New York, New York, United States
Research Site, New York, New York, United States
Research Site, Port Jefferson Station, New York, United States
Research Site, Jacksonville, North Carolina, United States
Research Site, Sparta, North Carolina, United States
Research Site, Cincinnati, Ohio, United States
Research Site, Oklahoma City, Oklahoma, United States
Research Site, Tulsa, Oklahoma, United States
Research Site, Greenville, South Carolina, United States
Research Site, Chattanooga, Tennessee, United States
Research Site, Nashville, Tennessee, United States
Research Site, Dallas, Texas, United States
Research Site, Dallas, Texas, United States
Research Site, Houston, Texas, United States
Research Site, Houston, Texas, United States
Research Site, Longview, Texas, United States
Research Site, Temple, Texas, United States
Research Site, Salt Lake City, Utah, United States
Research Site, Fairfax, Virginia, United States
Research Site, Fredericksburg, Virginia, United States
Research Site, Richmond, Virginia, United States
Research Site, Richmond, Virginia, United States
Research Site, Everett, Washington, United States
Research Site, Seattle, Washington, United States
Research Site, Tacoma, Washington, United States
Research Site, Vancouver, Washington, United States
Research Site, Morgantown, West Virginia, United States
Research Site, Milwaukee, Wisconsin, United States
Research Site, Viedma, Rio Negro, Argentina
Research Site, Buenos Aires, Argentina
Research Site, Buenos Aires, Argentina
Research Site, Buenos Aires, Argentina
Research Site, La Rioja, Argentina
Research Site, Waratah, New South Wales, Australia
Research Site, Bedford Park, South Australia, Australia
Research Site, Clayton, Victoria, Australia
Research Site, Heidelberg, Victoria, Australia
Research Site, Melbourne, Victoria, Australia
Research Site, Garran, Australia
Research Site, Innsbruck, Tyrol, Austria
Research Site, Wiener Neustadt, Austria
Research Site, Wien, Austria
Research Site, Edegem, Antwerpen, Belgium
Research Site, Brussels, Belgium
Research Site, Gent, Belgium
Research Site, Yvoir, Belgium
Research Site, Curitiba, Brazil
Research Site, Ijuí, Brazil
Research Site, Sao Paulo, Brazil
Research Site, São Paulo, Brazil
Research Site, São Paulo, Brazil
Research Site, São Paulo, Brazil
Research Site, São Paulo, Brazil
Research Site, Ottawa, Ontario, Canada
Research Site, Toronto, Ontario, Canada
Research Site, Montréal, Quebec, Canada
Research Site, Toronto, Canada
Research Site, Bengbu, Anhui, China
Research Site, Hefei, Anhui, China
Research Site, Hefei, Anhui, China
Research Site, Fuzhou, Fujian, China
Research Site, Guangzhou, Guang Dong, China
Research Site, Shenzhen, Guang Dong, China
Research Site, Nanning, Guangxi, China
Research Site, Harbin, Heilongjiang, China
Research Site, Zhengzhou, Henan, China
Research Site, Wuhan, Hubei, China
Research Site, Changsha, Hunan, China
Research Site, Changsha, Hunan, China
Research Site, Wuxi, Jiangsu, China
Research Site, Nanchang, Jiangxi, China
Research Site, Changchun, Jilin, China
Research Site, Changchun, Jilin, China
Research Site, Shenyang, Liaoning, China
Research Site, Shenyang, Liaoning, China
Research Site, Shanghai, Pudong, China
Research Site, Jinan, Shandong, China
Research Site, Chengdu, Sichuan, China
Research Site, Neijiang, Sichuan, China
Research Site, Hangzhou, Zhejiang, China
Research Site, Hangzhou, Zhejiang, China
Research Site, Beijing, China
Research Site, Beijing, China
Research Site, Shanghai, China
Research Site, Shanghai, China
Research Site, Shanghai, China
Research Site, Shanghai, China
Research Site, Tianjin, China
Research Site, Xi'an, China
Research Site, Floridablanca, Santander, Colombia
Research Site, Barranquilla, Colombia
Research Site, Bogotá, Colombia
Research Site, Medellín, Colombia
Research Site, Praha, Prague, Czechia
Research Site, Brno, South Moravian, Czechia
Research Site, Brno, South Moravian, Czechia
Research Site, Olomouc, Czechia
Research Site, Prague, Czechia
Research Site, Copenhagen, Denmark
Research Site, Odense, Denmark
Research Site, Vejle, Denmark
Research Site, Helsinki, Finland
Research Site, Tampere, Finland
Research Site, Turku, Finland
Research Site, Dijon, Bourgogne, France
Research Site, Brest, Bretagne, France
Research Site, Besançon, Doubs, France
Research Site, Lille, Hauts-de-France, France
Research Site, Paris, Ile-de-France, France
Research Site, Toulouse, Midi-Pyrenees, France
Research Site, Avignon, Provence Alpes Cote d'Azure, France
Research Site, Lyon, Rhone-Alpes, France
Research Site, Bourdeaux, Rhone, France
Research Site, Villejuif, Val-de-Marne, France
Research Site, Marseille, France
Research Site, Paris, France
Research Site, Paris, France
Research Site, Paris, France
Research Site, Pessac, France
Research Site, Suresnes, France
Research Site, Tours, France
Research Site, Reutlingen, Baden-Wurttemberg, Germany
Research Site, München, Bayern, Germany
Research Site, Frankfurt, Hessen, Germany
Research Site, Bochum, Nordrhein-Westfalen, Germany
Research Site, Dresden, Sachsen, Germany
Research Site, Amberg, Germany
Research Site, Berlin, Germany
Research Site, Hamburg, Germany
Research Site, Herne, Germany
Research Site, Monchengladbach, Germany
Research Site, München, Germany
Research Site, Larissa, Thessaly, Greece
Research Site, Athens, Greece
Research Site, Athens, Greece
Research Site, Heraklion, Greece
Research Site, Thessaloniki, Greece
Research Site, Thessaloníki, Greece
Research Site, Central, Hong Kong
Research Site, Hong Kong, Hong Kong
Research Site, Dublin, Ireland
Research Site, Dublin, Ireland
Research Site, Dublin, Ireland
Research Site, Dublin, Ireland
Research Site, Anyang-si, Gyeonggi-do, Korea, Republic of
Research Site, Seongnam-si, Gyeonggi-do, Korea, Republic of
Research Site, Yangsan, Gyeongsangnam, Korea, Republic of
Research Site, Hwasun, Jeollanam-do, Korea, Republic of
Research Site, Busan, Korea, Republic of
Research Site, Busan, Korea, Republic of
Research Site, Daejeon, Korea, Republic of
Research Site, Goyang-si, Korea, Republic of
Research Site, Seoul, Korea, Republic of
Research Site, Seoul, Korea, Republic of
Research Site, Seoul, Korea, Republic of
Research Site, Seoul, Korea, Republic of
Research Site, Seoul, Korea, Republic of
Research Site, Sŏwŏn, Korea, Republic of
Research Site, Kuala Lumpur, Selangor, Malaysia
Research Site, Kuala Lumpur, Selangor, Malaysia
Research Site, Petaling Jaya, Selangor, Malaysia
Research Site, Johor Bahru, Malaysia
Research Site, Putrajaya, Malaysia
Research Site, Tuxtla Gutiérrez, Chiapas, Mexico
Research Site, Guadalajara, Jalisco, Mexico
Research Site, Cuernavaca, Morelos, Mexico
Research Site, San Juan Del Río, Queretaro, Mexico
Research Site, Mexico City, Mexico
Research Site, Veracruz, Mexico
Research Site, Nijmegen, Gelderland, Netherlands
Research Site, Amsterdam, Noord-Holland, Netherlands
Research Site, Nieuwegein, Utrecht, Netherlands
Research Site, Gdańsk, Poland
Research Site, Otwock, Poland
Research Site, Warsaw, Poland
Research Site, Braga, Portugal
Research Site, Lisboa, Portugal
Research Site, Lisbon, Portugal
Research Site, Porto, Portugal
Research Site, San Juan, Puerto Rico
Research Site, San Juan, Puerto Rico
Research Site, Braşov, Romania
Research Site, Cluj-Napoca, Romania
Research Site, Cluj-Napoca, Romania
Research Site, Singapore, Singapore
Research Site, Singapore, Singapore
Research Site, Singapore, Singapore
Research Site, Singapore, Singapore
Research Site, Badalona, Barcelona, Spain
Research Site, A Coruña, Spain
Research Site, Barcelona, Spain
Research Site, Barcelona, Spain
Research Site, Barcelona, Spain
Research Site, Córdoba, Spain
Research Site, Madrid, Spain
Research Site, Madrid, Spain
Research Site, Madrid, Spain
Research Site, Madrid, Spain
Research Site, Pamplona, Spain
Research Site, Sabadell, Spain
Research Site, Santander, Spain
Research Site, Valencia, Spain
Research Site, Valencia, Spain
Research Site, Kaohsiung, Taiwan
Research Site, Taichung, Taiwan
Research Site, Tainan, Taiwan
Research Site, Tainan, Taiwan
Research Site, Taipei, Taiwan
Research Site, Taoyuan, Taiwan
Research Site, Bangkok, Thailand
Research Site, Bangkok, Thailand
Research Site, Bangkok, Thailand
Research Site, Chiang Mai, Thailand
Research Site, Hat Yai, Thailand
Research Site, Bournemouth, Dorset, United Kingdom
Research Site, Birmingham, England, United Kingdom
Research Site, Cambridge, England, United Kingdom
Research Site, Leeds, England, United Kingdom
Research Site, London, England, United Kingdom
Research Site, Maidstone, England, United Kingdom
Research Site, Manchester, England, United Kingdom
Research Site, Middlesex, England, United Kingdom
Research Site, Aberdeen, Scotland, United Kingdom
Research Site, Glasgow, Scotland, United Kingdom
A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer
- Stato: In arruolamento
- Fascia d'età: Bambini, AdultiAnziani
- Codice Sperimentazione: NCT05217446
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Policlinico Universitario Monserrato, Monserrato, Cagliari, Italy
Azienda Ospedaliera Universitaria dell'Università "Luigi Vanvitelli" Piazza Luigi Miraglia, 2 Napol, Napoli, Campania, Italy
Ospedale di Guastalla, Guastalla, Emilia-romagna, Italy
IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy
ASST Grande Ospedale Metropolitano Niguarda, Milan, Milano, Italy
Istituto di Candiolo IRCCS - Fondazione del Piemonte per l'Oncologia, Candiolo, Torino, Italy
Azienda USL Toscana Nord Ovest_Ospedale Civile di Livorno, Livorno, Toscana, Italy
Azienda Ospedaliera Universitaria Pisana, Pisa, Toscana, Italy
Istituto Oncologico Veneto IRCCS, Padova, Veneto, Italy
Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy
Istituto Europeo di Oncologia IRCCS, Milano, Italy
Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
Mayo Clinic Building - Phoenix, Phoenix, Arizona, United States
Mayo Clinic Hospital, Phoenix, Arizona, United States
Mayo Clinic, Scottsdale, Arizona, United States
Keck Hospital of USC, Los Angeles, California, United States
Keck School of Medicine of USC, Los Angeles, California, United States
LAC USC Medical Center, Los Angeles, California, United States
USC Norris Comprehensive Cancer Center, Los Angeles, California, United States
USC/Norris Comprehensive Cancer Center / Investigational Drug Services, Los Angeles, California, United States
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
Keck Hospital of USC Pasadena, Pasadena, California, United States
Mount Sinai Cancer Center, Miami Beach, Florida, United States
Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester, Minnesota, United States
Mayo Clinic, Rochester, Minnesota, United States
Columbia University Medical Center, New York, New York, United States
The West Clinic, PLLC dba West Cancer Center, Germantown, Tennessee, United States
MD Anderson Cancer Center, Houston, Texas, United States
Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia
GenesisCare North Shore, St Leonards, New South Wales, Australia
Gallipoli Medical Research Foundation, Brisbane, Queensland, Australia
Greenslopes Private Hospital, Greenslopes, Queensland, Australia
Austin Health, Heidelberg, Victoria, Australia
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Royal Melbourne Hospital, Parkville, Victoria, Australia
Imelda General Hospital, Bonheiden, Antwerpen, Belgium
Institut Jules Bordet, Anderlecht, Bruxelles-capitale, Région DE, Belgium
Cliniques universitaires Saint-Luc, Brussels, Bruxelles-capitale, Région DE, Belgium
UZ Gent, Gent, Oost-vlaanderen, Belgium
ZNA Middelheim, Antwerpen, Belgium
William Osler Health System, Brampton, Ontario, Canada
The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada
Sunnybrook Health Sciences - Odette Cancer Centre, Toronto, Ontario, Canada
Saskatoon Cancer Center, Saskatoon, Saskatchewan, Canada
Fakultni nemocnice Hradec Kralove, Hradec Kralove, Hradec Králové, Czechia
Fakultni nemocnice Olomouc, Olomouc, Olomoucký KRAJ, Czechia
Fakultni Thomayerova nemocnice, Prague, Praha 4, Czechia
Fakultni nemocnice Bulovka, Prague, Praha 8, Czechia
Rigshospitalet, Copenhagen, Hovedstaden, Denmark
Herlev and Gentofte Hospital, Copenhagen, Hovedstaden, Denmark
Aalborg Universitetshospital, Syd, Aalborg, Nordjylland, Denmark
Hôpital Européen Georges Pompidou, Paris Cedex 15, Paris, France
CHU Estaing, Clermont Ferrand, France
Centre Hospitalier Universitaire Estaing, Clermont-Ferrand, France
Institut Régional du Cancer Montpellier, Montpellier, France
Hôpital Saint Antoine, Paris, France
Muenchen Klinik Neuperlach, Klinik fuer Haematologie und Onkologie, Muenchen, Bayern, Germany
Institut für Klinisch Onkologische Forschung, Frankfurt, Hessen, Germany
Klinikum Oldenburg, Oldenburg, Niedersachsen, Germany
Studiengesellschaft BSF Unternehmergesellschaft, Halle (Saale), Sachsen-anhalt, Germany
Universitätsklinikum Leipzig, Leipzig, Sachsen, Germany
Onkologische Schwerpunktpraxis Kurfuerstendamm, Berlin, Germany
Studiengesellschaft BSF UG, Halle /Saale, Germany
Facharztzentrum Eppendorf, Hamburg, Germany
Maastricht UMC+, Maastricht, Limburg, Netherlands
Haaglanden MC - locatie Antoniushove, Leidschendam, Zuid-holland, Netherlands
St. Olavs Hospital, Trondheim, Sør-trøndelag, Norway
Oslo Universitetssykehus Ullevål, Oslo, Norway
Przychodnia Lekarska KOMED, Konin, Wielkopolskie, Poland
Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza, Brzozow, Poland
SPZOZ Wojewodzki Szpital Specjalistyczny nr 4 w Bytomiu, Bytom, Poland
Copernicus Podmiot Leczniczy Sp. z o.o. Wojewodzkie Centrum Onkologii, Gdansk, Poland
Radomskie Centrum Onkologii im. Bohaterow Radomskiego Czerwca 76, Radom, Poland
Fakultna nemocnica s poliklinikou F. D. Roosevelta Banska Bystrica, Banska Bystrica, Slovakia
Onkologicky ustav sv. Alzbety, s.r.o., Bratislava, Slovakia
Narodny onkologicky ustav, Bratislava, Slovakia
Vychodoslovensky onkologicky ustav, a.s., Kosice, Slovakia
CHUS - Hospital Clinico Universitario, Santiago de Compostela, A Coruña [LA Coruña], Spain
Hospital General Universitario de Elche, Elche, Alicante, Spain
Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [barcelona], Spain
Hospital Clínic de Barcelona, Barcelona, Catalunya [cataluña], Spain
Institut Català d'Oncologia - L'Hospitalet, L'Hospitalet de Llobregat, Catalunya [cataluña], Spain
Hospital Universitario Ramón y Cajal, Madrid, Madrid, Comunidad DE, Spain
Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad DE, Spain
Hospital General Universitario Gregorio Marañon, Madrid, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Hospital Universitario Virgen Del Rocio, Sevilla, Spain
Hospital General Universitario de Valencia, Valencia, Spain
Hospital Universitario Miguel Servet, Zaragoza, Spain
Karolinska Universitetssjukhuset Solna, Solna, Stockholms LÄN [se-01], Sweden
Skaraborgs Sjukhus Skövde, Skövde, Sweden
Aberdeen Royal Infirmary, Aberdeen, Aberdeen CITY, United Kingdom
Guy's & St Thomas's NHS Foundation Trust, London, England, United Kingdom
Guy's & St Thomas' NHS Foundation Trust, London, London, CITY OF, United Kingdom
Heartlands Hospital, Birmingham, United Kingdom
A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05608044
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
IRCCS Azienda Ospedaliera Universitaria San Martino IST, Genova, Italy
Fondazione IRCCS Instituto Nazionale dei Tumori, Milano, Italy
ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
Istituto Oncologico Veneto, Padova, Italy
Azienda Ospedaliero Universitaria Pisana - Stabilimento di Santa Chiara, Pisa, Italy
HonorHealth Research Institute, Scottsdale, Arizona, United States
City of Hope National Medical Center, Duarte, California, United States
Keck School of Medicine of the University of Southern California, Los Angeles, California, United States
Rocky Mountain Cancer Center - Aurora, Aurora, Colorado, United States
University of Colorado, Denver, Colorado, United States
Medical Oncology Hematology Consultants, Newark, Delaware, United States
Florida Cancer Specialists and Research Institute - Lake Mary, Lake Mary, Florida, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
University of Michigan, Ann Arbor, Michigan, United States
Atlantic Health System - Morristown Medical Center, Morristown, New Jersey, United States
Weill Cornell Medical College, New York, New York, United States
Mount Sinai Hospital - New York, New York, New York, United States
Memorial Sloan Kettering, New York, New York, United States
Cleveland Clinic, Cleveland, Ohio, United States
Earle A. Chiles Research Institute - Robert W. Franz Cancer Center - Providence Cancer Institute, Portland, Oregon, United States
Oregon Health & Science University (OHSU), Portland, Oregon, United States
Lifespan Clinical Research Center/Cancer Institute (Providence Rhode Island), East Providence, Rhode Island, United States
Tennessee Oncology Nashville (Sarah Cannon), Nashville, Tennessee, United States
Vanderbilt University School of Medicine, Nashville, Tennessee, United States
Texas Oncology - Austin Midtown, Austin, Texas, United States
Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas, United States
MDACC, Houston, Texas, United States
Virginia Cancer Specialists/ NEXT Virginia, Fairfax, Virginia, United States
Swedish Cancer Institute, Seattle, Washington, United States
Antwerp University Hospital (UZA), Edegem, Belgium
Universitair Ziekenhuis Leuven, Leuven, Belgium
Service d'Oncologie Medicale - CHRU Besancon, Besançon, France
Centre Georges Francois Leclerc, Dijon, France
Hôpital Saint Antoine/AP-HP Hopital Saint Antoine (Pierre and Marie Curie University), Paris, France
CHU Poitiers - Pole Regional de Cancerologie de Poitiers (PRC), Poitiers, France
Unversite Paris-Saclay Gustave Roussy Cancer Center Campus Paris, Villejuif, France
Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Clínica Universidad de Navarra - Sede Madrid, Madrid, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Hospital Universitario Marques de Valdecilla, Santander, Spain
MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01)
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04495621
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1, Fase 2
Azienda Ospedaliero Universitaria San Martino, Genoa, Italy
Istituto Europeo di Oncologia (IEO), Milan, Italy
Azienda Socio Sanitaria Territoriale Niguarda, Milan, Italy
Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
Istituto Clinico Humanitas, Rozzano, Italy
Mayo Clinic Arizona, Phoenix, Arizona, United States
The Oncology Institute of Hope and Innovation, Anaheim, California, United States
MultiCare Health System Institute for Research and Innovation, Tacoma, Washington, United States
ICO - Site Paul Papin, Angers, France
Centre Georges François Leclerc, Dijon, France
ICO - Site René Gauducheau, Saint-Herblain, France
Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin, Germany
Universitaetsklinikum Carl Gustav Carus TU Dresden, Dresden, Germany
Klinikum der Universitaet Muenchen Campus Grosshadern, Munich, Germany
Munich, Munich, Germany
Universitaetsklinikum Tuebingen, Tuebingen, Germany
Amsterdam University Medical Center, Amsterdam, Netherlands
Maastricht University Medical Center, Maastricht, Netherlands
Radboud Nijmegen, Nijmegen, Netherlands
Erasmus Medisch Centrum, Rotterdam, Netherlands
Examen sp. z o.o., Skórzewo, Poland
Centrum Onkologii-Instytut im.M.Sklodowskiej Curie, Warsaw, Poland
Hospital Universitari Vall d'Hebron, Barcelona, Spain
Hospital Universitario Ramon y Cajal, Madrid, Spain
Fundacion Jimenez Diaz, Madrid, Spain
Centro Integral Oncologico Clara Campal, Madrid, Spain
Hospital Clinico Universitario de Valencia, Valencia, Spain
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05379595
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1, Fase 2
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
A.O. Ospedale Niguarda Ca' Granda, Milano, Italy
Fondazione G. Pascale - Istituto Nazionale Tumori IRCCS, Napoli, Italy
Istituto Oncologico Veneto - IRCCS, Padova, Italy
Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
University of Alabama at Birmingham - The Kirklin Clinic, Birmingham, Alabama, United States
City of Hope, Duarte, California, United States
University of Southern California, Los Angeles, California, United States
Los Angeles VA Health Care System, Los Angeles, California, United States
University of California, Los Angeles UCLA, Los Angeles, California, United States
University of Colorado - Anschutz Medical Campus, Aurora, Colorado, United States
Georgetown University Hospital, Washington, District of Columbia, United States
H. Lee Moffitt Cancer Center, Tampa, Florida, United States
Ochsner Clinic Foundation, New Orleans, Louisiana, United States
University of Maryland School of Medicine, Baltimore, Maryland, United States
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
University of Michigan Health System, Ann Arbor, Michigan, United States
Start Midwest, Grand Rapids, Michigan, United States
Hattiesburg Clinic, Hattiesburg, Mississippi, United States
NYU Langone Long Island Clinical Research Associates, New York, New York, United States
Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Mayo Clinic Rochester, Rochester, New York, United States
Duke Cancer Institute, Durham, North Carolina, United States
Stephenson Cancer Center, Oklahoma City, Oklahoma, United States
Vanderbilt - Ingram Cancer Center, Nashville, Tennessee, United States
MD Anderson Cancer Center, Houston, Texas, United States
McGuire Veterans Affairs Medical Center, Richmond, Virginia, United States
University of Washington, Seattle, Washington, United States
Institut Jules Bordet, Anderlecht, Belgium
Cliniques Universitaires Saint-Luc, Brussel, Belgium
UZ Antwerpen, Edegem, Belgium
Universitair Ziekenhuis Gasthuisberg, Leuven, Belgium
Cross Cancer Institute, Edmonton, Alberta, Canada
BC Cancer Agency - Vancouver BC, Vancouver, British Columbia, Canada
The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada
Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada
Jilin cancer hospital, Changchun, China
Sichuan University West China Hospital Cancer Center, Chengdu, China
The Second Hospital To Dalian Medical University, Da Lian Shi, China
Sun Yat-sen University - The Sixth Affiliated Hospital Guangdong Gastrointestinal Hospital, Guangzhou, China
No.1 Affiliated Hospital, Medical College of Zhejiang University, Hangzhou, China
The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, China
Fudan University Shanghai Cancer Center, Shanghai, China
Hubei province tumor hospital, Wu Han Shi, China
Centre Hospitalier Regional Universitaire Besancon, Besancon, France
CHU Estaing, Clermont Ferrand, France
Centre Georges François Leclerc, Dijon, France
Centre Jean Bernard - Clinique Victor Hugo, Le Mans, France
Centre Leon Bérard, Lyon Cedex 8, France
CHU De Poitiers, Poitiers, France
Gustave Roussy, Villejuif Cedex, France
Helios Kliniken Berlin Buch Gmbh, Berlin, Germany
Katholisches Klinikum Bochum gGmbH, Bochum, Germany
Onkologische Gemeinschaftspraxis am Bethanien-Krankenhaus, Frankfurt, Germany
Asklepios Klinik Altona, Hamburg, Germany
Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany
Seoul National University Hospital, Seoul, Korea, Republic of
Asan Medical Center, Seoul, Korea, Republic of
Samsung Medical Center, Seoul, Korea, Republic of
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea, Republic of
Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of
University Malaya Medical Centre, Kuala Lumpur, Malaysia
Hospital Umum Sarawak, Kuching, Malaysia
Beacon Hospital Sdn. Bhd., Petaling Jaya, Malaysia
Ad-Vance Medical Research, Ponce, Puerto Rico
Pan American Center for Oncology Trials LLC, Rio Piedras, Puerto Rico
Hosp. Univ. Vall D Hebron, Barcelona, Spain
Hosp. de La Santa Creu I Sant Pau, Barcelona, Spain
Hosp. Gral. Univ. Gregorio Marañon, Madrid, Spain
Hosp. Univ. Ramon Y Cajal, Madrid, Spain
Hosp. Univ. Fund. Jimenez Diaz, Madrid, Spain
Hosp. Univ. 12 De Octubre, Madrid, Spain
Hosp. Univ. Hm Sanchinarro, Madrid, Spain
Hosp. Univ. Marques De Valdecilla, Santander, Spain
Hosp. Clinico Univ. De Valencia, Valencia, Spain
Changhua Christian Hospital, Changhua, Taiwan
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
Chi Mei Medical Center - Liu Ying, Liou Ying Township, Taiwan
National Cheng Kung University Hospital, Tainan, Taiwan
National Taiwan University Hospital, Taipei, Taiwan
Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan
Bristol Haematology and Oncology Centre, Bristol, United Kingdom
Royal Marsden Hospital, London, United Kingdom
Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom
Royal Marsden Hospital, Sutton, United Kingdom
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04929223
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1
Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 1, Milano, Lombardia, Italy
Azienda Socio Sanitaria Territoriale Niguarda (Ospedale Niguarda Ca' Granda); Oncologico -Onc.Falck, Milano, Lombardia, Italy
IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Prima, Padova, Veneto, Italy
UAB Comprehensive Cancer Center; Clinical Studies Unit, Birmingham, Alabama, United States
Mayo Clinic Arizona, Phoenix, Arizona, United States
City of Hope Comprehensive Cancer Center, Duarte, California, United States
USC Norris Cancer Center, Los Angeles, California, United States
Cedars-Sinai Medical Center, Los Angeles, California, United States
UCLA, Los Angeles, California, United States
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
Stanford Cancer Center, Stanford, California, United States
University of Colorado Cancer Center, Aurora, Colorado, United States
Mayo Clinic in Florida; Department of Hematology, Jacksonville, Florida, United States
Moffitt Cancer Center, Tampa, Florida, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center, Harvard Medical School; Department of Medicine, Boston, Massachusetts, United States
Mayo Clinic Rochester, Rochester, Minnesota, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Duke University Medical Center, Durham, North Carolina, United States
Hematology Oncology Salem, Salem, Oregon, United States
UPMC - Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
SCRI-Tennessee Oncology, Nashville, Tennessee, United States
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Medical Oncology Associates, Spokane, Washington, United States
Princess Margaret Cancer Center, Toronto, Ontario, Canada
Jewish General Hospital; Clinical Research Unit, Montreal, Quebec, Canada
McGill University Health Center, Montreal, Quebec, Canada
Seoul National University Bundang Hospital, Seongnam-si, Korea, Republic of
Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of
Seoul National University Hospital, Seoul, Korea, Republic of
Asan Medical Center, Seoul, Korea, Republic of
Samsung Medical Center, Seoul, Korea, Republic of
Vall d?Hebron Institute of Oncology (VHIO), Barcelona, Barcelona, Spain
START Madrid. Centro Integral Oncologico Clara Campal; CIOCC, Madrid, Spain
Addenbrookes Hospital, Cambridge, United Kingdom
Velindre Cancer Centre, Cardiff, United Kingdom
Sarah Cannon Research Institute, London, United Kingdom
Imperial College Healthcare NHS Trust, London, United Kingdom
The Christie NHS Foundation Trust, Manchester, United Kingdom
Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04952753
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Rozzano, MI, Italy
University of Michigan Medical Center, Ann Arbor, Michigan, United States
Washington University School of Medicine, Saint Louis, Missouri, United States
Astera Cancer Center, East Brunswick, New Jersey, United States
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Novartis Investigative Site, Adelaide, South Australia, Australia
Novartis Investigative Site, Bendigo, Victoria, Australia
Novartis Investigative Site, Perth, Western Australia, Australia
Novartis Investigative Site, Bruxelles, Belgium
Novartis Investigative Site, Leuven, Belgium
Novartis Investigative Site, Cambridge, Ontario, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Brno, Czech Republic, Czechia
Novartis Investigative Site, Hradec Kralove, CZE, Czechia
Novartis Investigative Site, Praha 4, Czechia
Novartis Investigative Site, Avignon Cedex, France
Novartis Investigative Site, Creteil, France
Novartis Investigative Site, Reims, France
Novartis Investigative Site, Berlin, Germany
Novartis Investigative Site, Bochum, Germany
Novartis Investigative Site, Dresden, Germany
Novartis Investigative Site, Essen, Germany
Novartis Investigative Site, Frankfurt, Germany
Novartis Investigative Site, Hamburg, Germany
Novartis Investigative Site, Ulm, Germany
Novartis Investigative Site, Pokfulam, Hong Kong
Novartis Investigative Site, Shatin, New Territories, Hong Kong
Novartis Investigative Site, Haifa, Israel
Novartis Investigative Site, Petach Tikva, Israel
Novartis Investigative Site, Nagoya, Aichi, Japan
Novartis Investigative Site, Kashiwa, Chiba, Japan
Novartis Investigative Site, Kawasaki-city, Kanagawa, Japan
Novartis Investigative Site, Osaka-city, Osaka, Japan
Novartis Investigative Site, Seoul, Korea, Republic of
Novartis Investigative Site, Singapore, Singapore
Novartis Investigative Site, Sabadell, Barcelona, Spain
Novartis Investigative Site, Santander, Cantabria, Spain
Novartis Investigative Site, Barcelona, Catalunya, Spain
Novartis Investigative Site, Barcelona, Catalunya, Spain
Novartis Investigative Site, Madrid, Spain
Novartis Investigative Site, St. Gallen, Switzerland
Novartis Investigative Site, Tainan, Taiwan
Novartis Investigative Site, Taipei, Taiwan
Novartis Investigative Site, Aberdeen, Scotland, United Kingdom
Novartis Investigative Site, Cambridge, United Kingdom
Novartis Investigative Site, Oxford, United Kingdom
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
- Stato: In arruolamento
- Fascia d'età: Bambini, AdultiAnziani
- Codice Sperimentazione: NCT04607421
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 3
Azienda Ospedaliera Universitaria di Cagliari - Presidio Policlinico Universitario "D.Casula", Monserrato (CA), Cagliari, Italy
IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy
ASST Grande Ospedale Metropolitano Niguarda, Milan, Milano, Italy
Fondazione del Piemonte per l'Oncologia - Istituto di Candiolo IRCCS, Candiolo, Torino, Italy
Azienda Ospedaliero Universitaria San Luigi Gonzaga, Orbassano, Torino, Italy
Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy
Istituto Europeo di Oncologia IRCCS, Milano, Italy
Azienda Ospedaliera Universitaria dell'Università "Luigi Vanvitelli" di Napoli, Napoli, Italy
IRCCS Istituto Oncologico Veneto (IOV), Padova, Italy
Azienda USL - IRCCS di Reggio Emilia - Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
Mayo Clinic - Phoenix Oncology Pharmacy, Phoenix, Arizona, United States
Mayo Clinic Hospital, Phoenix, Arizona, United States
Mayo Clinic in Arizona - Scottsdale, Scottsdale, Arizona, United States
Tower Hematology Oncology Medical Group (THO), Beverly Hills, California, United States
Keck Hospital of USC, Los Angeles, California, United States
LAC & USC Medical Center, Los Angeles, California, United States
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
USC/Norris Comprehensive Cancer Center / Investigational Drug Services, Los Angeles, California, United States
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
Cedars- Sinai Medical Center, Los Angeles, California, United States
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, United States
Cedars-Sinai Medical Center, Los Angeles, California, United States
Keck Hospital of USC Pasadena, Pasadena, California, United States
Torrance Memorial Medical Center (TMMC), Torrance, California, United States
Georgetown University Medical Center, Washington, District of Columbia, United States
Medstar Georgetown University Hospital, Washington, District of Columbia, United States
Mount Sinai Comprehensive Cancer Center, Aventura, Aventura, Florida, United States
Sylvester Comprehensive Cancer Center- The Lennar Foundation Medical Center, Coral Gables, Florida, United States
Holy Cross Hospital - Michael and Dianne Bienes Comprehensive Cancer Center, Fort Lauderdale, Florida, United States
Mayo Clinic Florida, Jacksonville, Florida, United States
Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States
Mount Sinai Medical Center, Miami Beach, Florida, United States
Sylvester Comprehensive Cancer Center, Miami, Florida, United States
Baptist Hospital of Miami, Miami, Florida, United States
Miami Cancer Institute, Miami, Florida, United States
Orlando Health Cancer Institute, Orlando, Florida, United States
Orlando Health, Inc., Orlando, Florida, United States
Orlando Health, Inc, Orlando, Florida, United States
BRCR Global, Plantation, Florida, United States
BRCR Medical Center Inc., Plantation, Florida, United States
Lewis Cancer & Research Pavilion at St Joseph's/Candler Health System, Savannah, Georgia, United States
Lewis Cancer & Research Pavilion Pharmacy, Savannah, Georgia, United States
St. Joseph's/Candler Health System, Inc., Savannah, Georgia, United States
Summit Cancer Care, P.C., Savannah, Georgia, United States
Summit Cancer Care, Savannah, Georgia, United States
St. Joseph's/Candler Health System, Inc., Savannah, Georgia, United States
UChicago Medicine - River East, Chicago, Illinois, United States
The University of Chicago Medical Center, CCD - Investigational Drug Service Pharmacy, Chicago, Illinois, United States
University of Chicago Medical Center, Chicago, Illinois, United States
UChicago Medicine at Ingalls - Flossmoor, Flossmoor, Illinois, United States
UChicago Medicine Ingalls Memorial, Harvey, Illinois, United States
University of Chicago Comprehensive Cancer Center at Silver Cross Hospital, New Lenox, Illinois, United States
The University of Chicago Medicine Center for Advanced Care Orland Park, Orland Park, Illinois, United States
UChicago Medicine at Ingalls - Tinley Park, Tinley Park, Illinois, United States
Ochsner Clinic Foundation Research Pharmacy, New Orleans, Louisiana, United States
Ochsner Clinic Foundation, New Orleans, Louisiana, United States
University of Michigan Hospitals, Ann Arbor, Michigan, United States
University of Michigan, Ann Arbor, Michigan, United States
Mayo Clinic Rochester, Rochester, Minnesota, United States
Mayo Clinic, Rochester, Minnesota, United States
Siteman Cancer Center - West County, Creve Coeur, Missouri, United States
Siteman Cancer Center - North County, Florissant, Missouri, United States
Barnes- Jewish Hospital, Saint Louis, Missouri, United States
Washington University School of Medicine, Saint Louis, Missouri, United States
Siteman Cancer Center - South County, Saint Louis, Missouri, United States
Siteman Cancer Center - St Peters, Saint Peters, Missouri, United States
St Vincent Healthcare, Billings, Montana, United States
St. Vincent Frontier Cancer Center, Billings, Montana, United States
Oncology Hematology West PC dba Nebraska Cancer Specialists, Omaha, Nebraska, United States
Oncology Hematology West PC dba Nebraska Cancer Specialists, Omaha, Nebraska, United States
Oncology Hematology West PC dba Nebraska Cancer Specialists, Omaha, Nebraska, United States
Oncology Hematology West, PC dba Nebraska Cancer Specialists - IP Storage, Omaha, Nebraska, United States
Oncology Hematology West PC dba Nebraska Cancer Specialists, Papillion, Nebraska, United States
Memorial Sloan Kettering Cancer Center - Basking Ridge, Basking Ridge, New Jersey, United States
Summit Medical Group, Berkeley Heights, New Jersey, United States
Summit Medical Group, Florham Park, New Jersey, United States
Memorial Sloan Kettering Cancer Center- Monmouth, Middletown, New Jersey, United States
Memorial Sloan Kettering Cancer Center- Bergen, Montvale, New Jersey, United States
North Shore Hematology Oncology Assoc. P.C. DBA NY Cancer and Blood Specialists, Babylon, New York, United States
North Shore Hematology Oncology Assoc. P.C. DBA NY Cancer and Blood Specialists, Bronx, New York, United States
Memorial Sloan Kettering Cancer Center Commack, Commack, New York, United States
Memorial Sloan Kettering Cancer Center - Westchester, Harrison, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
North Shore Hematology Oncology Assoc. P.C. DBA NY Cancer and Blood Specialists, New York, New York, United States
Memorial Sloan Kettering Cancer Center - Main Campus, New York, New York, United States
North Shore Hematology Oncology Assoc. P.C. DBA NY Cancer and Blood Specialists, Patchogue, New York, United States
North Shore Hematology Oncology Assoc. P.C. DBA NY Cancer and Blood Specialists, Port Jefferson Station, New York, United States
North Shore Hematology Oncology Assoc. P.C. DBA NY Cancer and Blood Specialists, Riverhead, New York, United States
Memorial Sloan Kettering Cancer Center- Nassau, Uniondale, New York, United States
Carolinas Medical Center, Charlotte, North Carolina, United States
Carolinas Medical Center Investigational Drug Services, Charlotte, North Carolina, United States
Levine Cancer Institute, Charlotte, North Carolina, United States
Atrium Health Mercy, Charlotte, North Carolina, United States
Atrium Health Pineville, Charlotte, North Carolina, United States
Levine Cancer Institute - Southpark, Charlotte, North Carolina, United States
Atrium Health University City, Charlotte, North Carolina, United States
Levine Cancer Institute University City, Charlotte, North Carolina, United States
Atrium Health Cabarrus, Concord, North Carolina, United States
Levine Cancer Institute - Concord, Concord, North Carolina, United States
Atrium Health Union, Monroe, North Carolina, United States
Cleveland Clinic Taussig Cancer Center Investigational Pharmacy, Cleveland, Ohio, United States
Cleveland Clinic, Cleveland, Ohio, United States
Investigational Drug Service, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
The Ohio State University James Cancer Hospital and Solove Research Institute, Columbus, Ohio, United States
Stefanie Spielman Comprehensive Breast Cancer, Columbus, Ohio, United States
Martha Morehouse Medical Plaza, Columbus, Ohio, United States
University of Oklahoma Health Sciences Center, OU Health Stephenson Cancer Center, Oklahoma City, Oklahoma, United States
Providence Cancer Institute Franz Clinic, Portland, Oregon, United States
Providence Portland Medical Center, Portland, Oregon, United States
Providence Onc and Heme Care Clinic - Westside, Portland, Oregon, United States
Providence Oncology and Hematology Care Clinic - Westside, Portland, Oregon, United States
Providence St Vincent Medical Center, Portland, Oregon, United States
Providence St. Vincent Medical Center, Portland, Oregon, United States
AHN Cancer Institute at Jefferson Hospital, Jefferson Hills, Pennsylvania, United States
AHN Cancer Institute Forbes Hospital, Monroeville, Pennsylvania, United States
AHN Cancer Institute - Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
AHN Cancer Institute Pharmacy, Pittsburgh, Pennsylvania, United States
AHN Cancer Institute West Penn Hospital, Pittsburgh, Pennsylvania, United States
UPMC Hillman Cancer Center Investigational Drug Service, Pittsburgh, Pennsylvania, United States
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Wexford Health and Wellness Pavilion, Wexford, Pennsylvania, United States
Vanderbilt Health Clinic at Walgreens Clarksville, Clarksville, Tennessee, United States
Vanderbilt Health Clinic at Walgreens Cool Springs, Franklin, Tennessee, United States
Vanderbilt Health Clinic at Walgreens Gallatin, Gallatin, Tennessee, United States
The West Clinic. PLLC. dba West Cancer Center, Germantown, Tennessee, United States
Vanderbilt Health Clinic at Walgreens Hendersonville, Hendersonville, Tennessee, United States
Vanderbilt Health Clinic at Walgreens Hermitage, Hermitage, Tennessee, United States
Vanderbilt Health Clinic at Walgreens La Vergne, La Vergne, Tennessee, United States
Vanderbilt Health Clinic at Walgreens Lebanon, Lebanon, Tennessee, United States
The West Clinic PLLC dba West Cancer Center, Memphis, Tennessee, United States
Vanderbilt Health Clinic at Walgreens Murfreesboro, Murfreesboro, Tennessee, United States
Vanderbilt Health Clinic at Walgreens Belle Meade, Nashville, Tennessee, United States
Vanderbilt Health Clinic at Walgreens Nippers Corner, Nashville, Tennessee, United States
Vanderbilt Health Clinic at Walgreens Donelson, Nashville, Tennessee, United States
Vanderbilt Health Clinic at Walgreens Hart Lane, Nashville, Tennessee, United States
Vanderbilt Health Clinic at Walgreens Bellevue, Nashville, Tennessee, United States
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Henry-Joyce Cancer Center, Nashville, Tennessee, United States
Vanderbilt Oncology IDS Pharmacy, Nashville, Tennessee, United States
Vanderbilt Health Clinic at Walgreens Smyrna, Smyrna, Tennessee, United States
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
VCU Health System, Investigational Drug Service Pharmacy, Richmond, Virginia, United States
Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia, United States
Seattle Cancer Care Alliance, Seattle, Washington, United States
University of Washington Medical Center, Seattle, Washington, United States
University of Wisconsin Clinical Science Center, Madison, Wisconsin, United States
Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Centro Medico San Roque, San Miguel De Tucumán, Tucumán, Argentina
Centro Medico San Roque, Tucuman, Tucumán, Argentina
Instituto Médico Especializado Alexander Fleming, Ciudad Autónoma de Buenos Aires, Argentina
Clinica Universitaria Reina Fabiola, Cordoba, Argentina
Hospital Privado Centro Médico de Córdoba, Cordoba, Argentina
Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina
Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia
Liverpool Hospital, Liverpool, New South Wales, Australia
Slade Pharmacy, Mount Kuring-Gai, New South Wales, Australia
GenesisCare - North Shore, St Leonards, New South Wales, Australia
GenesisCare North Shore, St Leonards, New South Wales, Australia
Royal Brisbane & Women's Hospital, Herston, Queensland, Australia
Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
The Queen Elizabeth Hospital, Adelaide, South Australia, Australia
Monash Health, Clayton, Victoria, Australia
Austin Health, Heidelberg, Victoria, Australia
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Alfred Health, Melbourne, Victoria, Australia
Université Libre de Bruxelles - Hôpital Erasme, Brussels, Bruxelles-capitale, Région DE, Belgium
Cliniques universitaires Saint-Luc, Brussels, Bruxelles-capitale, Région DE, Belgium
Grand Hôpital de Charleroi, Charleroi, Hainaut, Belgium
CHR Verviers East Belgium, Verviers, Liège, Belgium
AZ Groeninge Campus Kennedylaan, Kortrijk, West-vlaanderen, Belgium
ZNA Middelheim, Antwerpen, Belgium
UZ Leuven, Leuven, Belgium
Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman, Liège, Belgium
Hospital Bruno Born, Lajeado, RIO Grande DO SUL, Brazil
Hospital Bruno Born, Lajeado, RIO Grande DO SUL, Brazil
Hospital Bruno Born, Lajeado, RIO Grande DO SUL, Brazil
Hospital de Clinicas de Porto Alegre, Porto Alegre, RIO Grande DO SUL, Brazil
INCA, Rio de Janeiro, RJ, Brazil
Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA, Rio de Janeiro, RJ, Brazil
Clinica de Oncologia Reichow, Blumenau, Santa Catarina, Brazil
Clínica de Neoplasias Litoral, Itajaí, Santa Catarina, Brazil
CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia - Faculdade de Medicina do ABC, Santo Andre, SP, Brazil
Fundacao do ABC-Faculdade de Medicina do ABC, Santo Andre, SP, Brazil
FUNDAÇÃO DO ABC - Faculdade de Medicina do ABC - Centro de Estudos e Pesquisas de Hematologia e On, Santo Andre, SP, Brazil
CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia - Faculdade de Medicina do ABC, Santo André, SP, Brazil
Instituto do Cancer do Estado de Sao Paulo, ICESP, Sao Paulo, SP, Brazil
Fundação Pio XII - Hospital de Câncer de Barretos, Barretos, SÃO Paulo, Brazil
Medical School Famerp-HB-FUNFARME_Do not use - Duplicate facility, Sao jose do Rio Preto, SÃO Paulo, Brazil
Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto, SÃO Paulo, Brazil
MHAT Uni Hospital OOD, Panagyurishte, Pazardzhik, Bulgaria
MHAT "Dr. Tota Venkova" AD, Gabrovo, Bulgaria
Complex Oncology Center - Plovdiv EOOD, Plovdiv, Bulgaria
MHAT Central Onco Hospital OOD, Plovdiv, Bulgaria
Complex Oncology Center - Plovdiv EOOD, Plovdiv, Bulgaria
Medical Center Nadezhda Clinical EOOD, Sofia, Bulgaria
Acibadem City Clinic MHAT Tokuda, Sofia, Bulgaria
University Multiprofile Hospital for Active Treatment Sofiamed, Sofia, Bulgaria
Tom Baker Cancer Centre, Calgary, Alberta, Canada
Cross Cancer Institute, Edmonton, Alberta, Canada
Kingston Health Sciences Centre-Kingston General Hospital Site, Kingston, Ontario, Canada
London Regional Cancer Program, London Health Sciences Centre, London, Ontario, Canada
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Centre Intégré de Santé et de Services Sociaux (CISSS) de Laval / Hôpital de la Cité-de-la-Sant, Laval, Quebec, Canada
Jewish General Hospital, Montreal, Quebec, Canada
Anhui Provincial Cancer Hospital, Hefei, Anhui, China
The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
Cancer Hospital Chinese Academy of Medical Science, Beijing, Beijing, China
Beijing Cancer hospital, Beijing, Beijing, China
Beijing Hospital, Beijing, Beijing, China
Chongqing University Cancer Hospital, Chongqing, Chongqing, China
Fujian Medical University Union Hospital-1 Bingfanglou, Fuzhou, Fujian, China
Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi, China
Henan provincial people's hospital, Zhengzhou, Henan, China
The Second Xiangya Hospital of Central South University, Changsha, Hunan, China
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China
Shengjing Hospital Of China Medical University, Shenyang, Liaoning, China
Jinan Central Hospital, Jinan, Shandong, China
Shandong province cancer hospital, Jinan, Shandong, China
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Shanghai Jiaotong University School of Medicine Ruijin Hospital, Shanghai, Shanghai, China
Shanghai General Hospital, Shanghai, Shanghai, China
Sichuan Province Cancer Hospital, Chengdu, Sichuan, China
Yunnan Cancer Hospital(The Third Affiliated Hospital of Kunming Medical University), Kunming, Yunnan, China
The second Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Peking University First Hospital, Beijing, China
Fudan University Shanghai Cancer Center, Shanghai, China
Tianjin Union Medical Center, Tianjin, China
Fakultní nemocnice Brno Bohunice, Brno, Brno-město, Czechia
Fakultni nemocnice Hradec Kralove, Hradec Kralove, Hradec Králové, Czechia
Fakultni Thomayerova nemocnice, Prague, Praha 4, Czechia
Fakultni nemocnice Olomouc, Olomouc, Czechia
Fakultni nemocnice v Motole, Praha 5, Czechia
Fakultni nemocnice Bulovka, Praha 8, Czechia
Aalborg Universitetshospital, Syd, Aalborg, Nordjylland, Denmark
Vejle Hospital-Sygehus Lillebaelt, Vejle, Syddanmark, Denmark
Vejle Sygehus, Vejle, Syddanmark, Denmark
Aalborg Universitetshospital, Aalborg, Denmark
Rigshospitalet, Copenhagen, Denmark
Herlev and Gentofte Hospital, Herlev, Denmark
Odense University Hospital, Odense C, Denmark
Docrates Syöpäsairaala, Helsinki, Nyland, Finland
Tampereen yliopistollinen sairaala, Tampere, Pirkanmaa, Finland
Helsinki University Central Hospital, Helsinki, Finland
Oulu University Hospital, Oulu, Finland
Satakunnan Keskussairaala, Pori, Finland
Turku University Hospital, Turku, Finland
Muenchen Klinik Neuperlach, Klinik fuer Haematologie und Onkologie, Muenchen, Bayern, Germany
Institut für Klinisch Onkologische Forschung, Frankfurt, Hessen, Germany
Medizinische Hochschule Hannover, Hannover, Lower Saxony, Germany
Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany
Universitätsklinikum Leipzig, Leipzig, Sachsen, Germany
Radiologie Berlin, Berlin - Charlottenburg, Germany
Onkologische Schwerpunktpraxis Kurfuerstendamm, Berlin, Germany
Waage Apotheke, Berlin, Germany
HELIOS Klinikum Berlin Buch GmbH, Berlin, Germany
Helios Klinikum Berlin-Buch, Berlin, Germany
Technische Universität Dresden, Medizinische Fakultät Carl Gustav Carus, Dresden, Germany
Universitätsklinikum Carl Gustav Carus Dresden, Dresden, Germany
Facharztzentrum Eppendorf, Hamburg, Germany
ZytoService Deutschland GmbH, Standort-Hamburg-Jenfeld, Hamburg, Germany
Radiologie im Israelitischen Krankenhaus, Hamburg, Germany
Klinikum Oldenburg AöR, Oldenburg, Germany
Klinikum Oldenburg AöR, Oldenburg, Germany
Rajiv Gandhi Cancer Institute And Research Centre, New Delhi, Delhi, India
Rajiv Gandhi Cancer Institute And Research Centre, New Delhi, Delhi, India
Tata Memorial Hospital, Mumbai, Maharashtra, India
Deenanath Mangeshkar Hospital & Research Centre, Pune, Maharashtra, India
Sahyadri Speciality Hospital, Pune, Maharashtra, India
Bhakti Vedanta Hospital and Research Institute, Thane, Maharashtra, India
R K Birla Cancer Center, SMS Hospital, Jaipur, Rajasthan, India
Sawai Man Singh Medical College Hospital (SMS Hospital), Jaipur, Rajasthan, India
Chiba cancer center, Chiba-shi, Chiba, Japan
National Cancer Center Hospital East, Kashiwa, Chiba, Japan
National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan
Hokkaido University Hospital, Sapporo, Hokkaido, Japan
Kanazawa University Hospital, Kanazawa, Ishikawa, Japan
St. Marianna University Hospital, Kawasaki, Kanagawa, Japan
Kanagawa cancer center, Yokohama, Kanagawa, Japan
Aichi Cancer Center Hospital, Nagoya, Nagoya, Aichi, Japan
Osaka Prefectural Hospital Organization Osaka International Cancer Institute, Osaka-shi, Osaka, Japan
Kindai University Hospital, Osakasayama, Osaka, Japan
Osaka University Hospital, Suita, Osaka, Japan
Osaka Medical and Pharmaceutical University Hospital, Takatsuki, Osaka, Japan
Saitama Medical University International Medical Center, Hidaka-city, Saitama, Japan
Saitama Prefectural Cancer Center, Ina-machi, Saitama, Japan
Shizuoka Cancer Center, Nagaizumi, Shizuoka, Japan
National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan
National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
National Hospital Organization - Osaka National Hospital - Institute For Clinical Research, Osaka, Japan
Keio University Hospital, Tokyo, Japan
National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of
Kyungpook National University Hospital, Daegu, Taegu-kwangyǒkshi, Korea, Republic of
Dong-A University Hospital, Busan, Korea, Republic of
Kyungpook National University Chilgok Hospital, Daegu, Korea, Republic of
Gachon University Gil Medical Center, Incheon, Korea, Republic of
Chonnam National University Hwasun Hospital Pharmacy, Jeonnam, Korea, Republic of
Chonnam National University Hwasun Hospital, Jeonnam, Korea, Republic of
Korea University Anam Hospital, Seoul, Korea, Republic of
Seoul National University Hospital, Seoul, Korea, Republic of
Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of
Asan Medical Center, Seoul, Korea, Republic of
Samsung Medical Center, Seoul, Korea, Republic of
Accelerium, S. de R.L. de C.V., Monterrey, Nuevo LEON, Mexico
Centro de Investigacion Clinica de Oaxaca, Oaxaca, Mexico
Maastricht UMC+, Maastricht, Limburg, Netherlands
Catharina Ziekenhuis, Eindhoven, Noord-brabant, Netherlands
Nederlands Kanker Instituut - Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, Noord-holland, Netherlands
Haaglanden Medisch Centrum, Leidschendam, Zuid-holland, Netherlands
Amsterdam UMC, location VUMc, Amsterdam, Netherlands
Maastricht University Medical Center, Maastricht, Netherlands
Universitair Medisch Centrum Utrecht, Utrecht, Netherlands
Tauranga Hospital, Tauranga, BAY OF Plenty, New Zealand
Auckland City Hospital, Auckland, New Zealand
Auckland District Health Board Charitable Trust, Auckland, New Zealand
Haukeland University Hospital, Bergen, Hordaland, Norway
Stavanger Universitetssykehus, Stavanger, Rogaland, Norway
St. Olavs hospital, Trondheim, Sør-trøndelag, Norway
Sørlandet Sykehus Kristiansand, Kristiansand, Vest-agder, Norway
Oslo universitetssykehus, Radiumhospitalet, Oslo, Norway
Oslo Universitetssykehus Ullevål, Oslo, Norway
Przychodnia Lekarska KOMED, Konin, Wielkopolskie, Poland
Szpital Specjalistyczny W Brzozowie, Podkarpacki Osrodek Onkologiczny Im.Ks.B.Markiewicza, Brzozow, Poland
Wojewodzki Szpital Specjalistyczny Nr 4 w Bytomiu Oddzial Onkologii, Bytom, Poland
COPERNICUS PL sp. z. o. o. Wojewodzkie Centrum Onkologii w Gdansku Ambulatoryjna, Gdansk, Poland
COPERNICUS Podmiot Leczniczy Sp. z o.o. Wojewodzkie Centrum Onkologii, Gdansk, Poland
Przychodnia Lekarska KOMED, Konin, Poland
Private Medical Institution "Euromedservice", Pushkin, Saint-petersburg, Russian Federation
Private Medical Institution "Euromedservice", Pushkin, Sankt-peterburg, Russian Federation
GBUZ, Chelyabinsk, Russian Federation
Kaluga Regional Clinical Oncology Center, Kaluga, Russian Federation
FSAEI HE I.M Sechenov First MSMU MoH Russia (Sechenovskiy University),, Moscow, Russian Federation
BHI of Omsk Region "Clinical Oncology Dispensary", Omsk, Russian Federation
BHI of Omsk Region "Clinical Oncology Dispensary", Omsk, Russian Federation
LLC "EuroCityClinic", Saint Petersburg, Russian Federation
LLC "Medicina Severnoy Stolitsy", Saint-Petersburg, Russian Federation
LLC "Severo-Zapadny Medical Center", Saint-Petersburg, Russian Federation
Private Healthcare Institution "Clinical Hospital "RZD-Medicine" of St. Petersburg, Saint-Petersburg, Russian Federation
FSBI "Russian Scientific Center For Radiology and Surgical Technologies n.a. Academician A.M. Granov, St. Petersburg, Russian Federation
SHI YR Regional Clinical Oncology Hospital, Yaroslavl, Russian Federation
SHI YR Regional Clinical Oncology Hospital, Yaroslavl, Russian Federation
SHI YR Regional Clinical Oncology Hospital, Yaroslav, Russian Federation
Fakultna nemocnica s poliklinikou F. D. Roosevelta Banska Bystrica, Banska Bystrica, Slovakia
Fakultna nemocnica s poliklinikou F. D. Roosevelta Banska Bystrica, Banska Bystrica, Slovakia
Onkologicky ustav sv. Alzbety s.r.o., Bratislava, Slovakia
Narodny Onkologicky Ustav, Bratislava, Slovakia
Vychodoslovensky onkologicky ustav, a.s., Kosice, Slovakia
POKO Poprad s.r.o., Poprad, Slovakia
Cancercare Rondebosch Oncology, Rondebosch, Cape Town, South Africa
Cancercare Langenhoven Drive Oncology Centre, Port Elizabeth, Eastern CAPE, South Africa
Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, Gauteng, South Africa
Wits Clinical Research, Parktown, Johannesburg, Gauteng, South Africa
Cape Town Oncology Trials, Cape Town, Western CAPE, South Africa
Mary Potter Oncology Centre, Pretoria, South Africa
Complejo Hospitalario Universitario Santiago de Compostela, Santiago de Compostela, A Coruña, Spain
Hospital General Universitario de Elche, Elche, Alicante, Spain
ICO L'Hospitalet (Hospital Duran i Reynals), Hospitalet de Llobregat, Barcelona, Spain
Hospital Universitario Vall d'Hebron, Barcelona, Spain
Hospital Clinic Barcelona, Barcelona, Spain
Hospital General Universitario Gregorio Marañon, Madrid, Spain
Hospital Universitario Ramon Y Cajal, Madrid, Spain
Hospital Universitario 12 de octubre, Madrid, Spain
Hospital Universitario Virgen Del Rocio, Sevilla, Spain
Hospital Clinico Universitario de Valencia, Valencia, Spain
Hospital General Universitario de Valencia, Valencia, Spain
Hospital Universitario Miguel Servet, Zaragoza, Spain
Karolinska Universitetssjukhuset Solna, Solna, Stockholms LÄN [se-01], Sweden
Akademiska sjukhuset, Uppsala, Uppsala LÄN [se-03], Sweden
Norrlands universitetssjukhus, Umeå, Västerbottens LÄN [se-24], Sweden
Sahlgrenska Universitetssjukhuset, Göteborg, Västra Götalands LÄN [se14], Sweden
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
China Medical University Hospital, Taichung, Taiwan
National Cheng-Kung University Hospital, Tainan, Taiwan
Chi Mei Hospital, Liouying, Tainan, Taiwan
National Taiwan University Hospital, Taipei, Taiwan
Taipei Medical University Hospital, Taipei, Taiwan
Taipei Veterans General Hospital, Taipei, Taiwan
Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan
Medical and diagnostic center of MediX-Ray International Group LLC Israeli Oncology Hospital "LISOD", Pliuty Village, KYIV Region, Obuhovskiy District, Ukraine
Municipal Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council, Dnipro, Ukraine
PRECARPATHIAN NUCLEAR MEDICINE CENTER, Limited Liability Company, Ivano-Frankivsk, Ukraine
Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine
MNPE "Prykarpatski Clinical Oncological Center" of Ivano-Frankivsk Regional Council", Ivano-Frankivsk, Ukraine
Municipal non-profit enterprise "City clinical hospital #2 named after O.O.Shalimov", Kharkiv, Ukraine
Communal Non-Profit Enterprise "Regional Center of Oncology", Kharkiv, Ukraine
Communal enterprise "Kryvyi Rih Oncology Dispensary" of Dnipropetrovsk Regional Council, Kryvyi Rih, Ukraine
SI "Insitute of Neurosurgery n.a.acad. A.P., Kyiv, Ukraine
SI "Insitute of Neurosurgery n.a.acad. A.P., Kyiv, Ukraine
Municipal non-profit enterprise of Kyiv regional council "Kyiv regional clinical hospital", Kyiv, Ukraine
Municipal non-profit enterprise "Zaporizhzhia Regional Antitumor Center" Zaporizhzhia Regional, Zaporizhzhia, Ukraine
Freeman Hospital, Newcastle upon Tyne, HIGH Heaton, United Kingdom
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Heartlands Hospital, Birmingham, United Kingdom
Royal Marsden NHS Foundation Trust, London, United Kingdom
Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
Churchill Hospital - Oncology, Oxford, United Kingdom
A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04008030
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 3
PO Garibaldi Nesima AORN Garibaldi, Catania, Italy
Local Institution - 0003, Genova, Italy
ASST Grande Ospedale Niguarda, Milan, Italy
AOU della Campania Luigi Vanvitelli, Napoli, Italy
I.O.V. Istituto Oncologico Veneto Ircss, Padova, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore, Roma, Italy
Local Institution, Gilbert, Arizona, United States
Usc/Norris Comprehensive Cancer Center, Los Angeles, California, United States
Local Institution - 0130, Sacramento, California, United States
Rocky Mountain Cancer Centers, Denver, Colorado, United States
Local Institution, Miami, Florida, United States
Local Institution, Marietta, Georgia, United States
Illinois Cancer Specialists, Arlington Heights, Illinois, United States
Memorial Sloan Kettering Nassau, New York, New York, United States
Northwest Cancer Specialists, P.C., Portland, Oregon, United States
Local Institution, Philadelphia, Pennsylvania, United States
Local Institution - 0121, Pittsburgh, Pennsylvania, United States
Texas Oncology Sammons Cancer Center, Dallas, Texas, United States
Local Institution, Fort Worth, Texas, United States
Oncology & Hematology Associates Of Southwest Virginia, Inc., Roanoke, Virginia, United States
Local Institution - 0073, Ciudad Autonoma Beunos Aires, Buenos Aires, Argentina
Local Institution - 0074, Viedma, RIO Negro, Argentina
Local Institution - 0190, San Miguel de Tucumán, Tucuman, Argentina
Local Institution - 0084, Buenos Aires, Argentina
Local Institution - 0100, Caba, Argentina
Local Institution - 0072, Caba, Argentina
Local Institution - 0019, Westmead, New South Wales, Australia
Local Institution - 0053, Woolloongabba, Queensland, Australia
Local Institution - 0018, Elizabeth Vale, South Australia, Australia
Local Institution - 0041, Clayton, Victoria, Australia
Local Institution - 0017, Heidelberg, Victoria, Australia
Local Institution - 0064, Graz, Austria
Local Institution - 0068, Linz, Austria
Local Institution - 0120, Salzburg, Austria
Local Institution - 0067, Wiener Neustadt, Austria
Local Institution - 0065, Wien, Austria
Local Institution - 0045, Bonheiden, Belgium
Local Institution, Brussel, Belgium
Local Institution - 0025, Bruxelles, Belgium
Local Institution - 0024, Leuven, Belgium
Local Institution - 0096, Ipatinga, Minas Gerais, Brazil
Local Institution - 0200, Natal, RIO Grande DO Norte, Brazil
Local Institution - 0192, Porto Alegre, RIO Grande DO SUL, Brazil
Local Institution - 0102, Barretos, Sao Paulo, Brazil
Local Institution - 0094, São José do Rio Preto, São Paulo, Brazil
Local Institution - 0199, Rio de Janeiro, Brazil
Local Institution - 0095, Sao Paulo, Brazil
Local Institution - 0193, São Paulo, Brazil
Local Institution - 0011, Edmonton, Alberta, Canada
Local Institution - 0039, Vancouver, British Columbia, Canada
Local Institution, Halifax, Nova Scotia, Canada
Local Institution - 0013, Toronto, Ontario, Canada
Local Institution - 0016, Montreal, Quebec, Canada
Local Institution - 0015, Sherbrooke, Quebec, Canada
Local Institution, Quebec, Canada
Local Institution - 0071, Santiago, Metropolitana, Chile
Local Institution - 0069, Santiago, Metropolitana, Chile
Local Institution - 0070, Independencia, Santiago, Chile
Local Institution - 0146, Hefei, Anhui, China
Local Institution, Fuzhou, Fujian, China
Local Institution - 0163, Xiamen, Fujian, China
Local Institution - 0207, Zhangzhou, Fujian, China
Local Institution - 0211, Lanzhou, Gansu, China
Local Institution - 0158, Foshan, Guangdong, China
Local Institution - 0167, Guangzhou, Guangdong, China
Local Institution - 0153, Guangzhou, Guangdong, China
Local Institution - 0149, Guangzhou, Guangdong, China
Local Institution - 0160, Nanning, Guangxi, China
Local Institution - 0196, Nanning, Guangxi, China
Local Institution - 0180, Harbin, Heilongjiang, China
Local Institution - 0181, Zhengzhou, Henan, China
Local Institution - 0197, Changsha, Hunan, China
Local Institution - 0145, Changzhou, Jiangsu, China
Local Institution - 0151, Nanchang, Jiangxi, China
Local Institution - 0164, Changchun, Jilin, China
Local Institution - 0162, Shenyang, Liaoning, China
Local Institution - 0188, Xi'an, Shaanxi, China
Local Institution - 0210, Jinan, Shandong, China
Local Institution - 0212, Linyi, Shandong, China
Local Institution - 0154, Qingdao, Shandong, China
Local Institution - 0165, Yantai, Shandong, China
Local Institution - 0143, Shanghai, Shanghai, China
Local Institution - 0131, Shanghai, Shanghai, China
Local Institution - 0195, Kunming, Yunnan, China
Local Institution - 0137, Hangzhou, Zhejiang, China
Local Institution - 0206, Ningbo, Zhejiang, China
Local Institution - 0087, Brno, Czechia
Local Institution - 0085, Hradec Kralove, Czechia
Local Institution - 0088, Novy Jicin, Czechia
Local Institution - 0086, Olomouc, Czechia
Local Institution - 0038, Herlev, Denmark
Local Institution, Odense, Denmark
Local Institution - 0036, Vejle, Denmark
Local Institution - 0176, Limoges, Haute-Vienne, France
Local Institution - 0186, Bayonne, France
Local Institution - 0028, Besancon Cedex, France
Local Institution - 0138, Lille, France
Local Institution - 0029, Lyon Cedex 08, France
Local Institution - 0183, Lyon, France
Local Institution - 0066, Marseille, France
Local Institution - 0030, Montpellier, France
Local Institution - 0032, Nantes, France
Local Institution - 0027, Paris, France
Local Institution - 0061, Pessac Cedex, France
Local Institution - 0031, Poitiers, France
Local Institution, Rouen, France
Local Institution - 0184, Strasbourg, France
Local Institution - 0040, Toulouse, France
Local Institution - 0042, Dresden, Germany
Local Institution - 0007, Essen, Germany
Local Institution - 0043, Hamburg, Germany
Local Institution - 0117, Hamburg, Germany
Local Institution - 0008, Hannover, Germany
Local Institution - 0009, Heidelberg, Germany
Local Institution - 0044, Marburg, Germany
Local Institution - 0010, Munich, Germany
Local Institution - 0123, Athens, Greece
Local Institution - 0125, Heraklion, Greece
Local Institution - 0124, Holargos, Greece
Local Institution - 0126, Ioannina, Greece
Local Institution - 0091, Dublin 8, Dublin, Ireland
Local Institution - 0022, Dublin, Ireland
Local Institution - 0026, Limerick, Ireland
Local Institution - 0109, Nagoya-shi, Aichi, Japan
Local Institution - 0112, Chiba-shi, Chiba, Japan
Local Institution - 0107, Kashiwa-shi, Chiba, Japan
Local Institution - 0132, Matsuyama, Ehime, Japan
Local Institution - 0116, Fukuoka-shi, Fukuoka, Japan
Local Institution - 0174, Sapporo-shi, Hokkaido, Japan
Local Institution - 0128, Kanazawa-city, Ishikawa, Japan
Local Institution - 0111, Kawasaki-shi, Kanagawa, Japan
Local Institution - 0175, Yokohama, Kanagawa, Japan
Local Institution - 0133, Kumamoto-shi, Kumamoto, Japan
Local Institution - 0189, Osaki, Miyagi, Japan
Local Institution - 0177, Kurashiki, Okayama, Japan
Local Institution - 0115, Suita-shi, Osaka, Japan
Local Institution - 0187, Hidaka, Saitama, Japan
Local Institution - 0110, Kitaadachigun, Saitama, Japan
Local Institution - 0108, Sunto-gun, Shizuoka, Japan
Local Institution - 0118, Chuo-ku, Tokyo, Japan
Local Institution - 0113, Koto-ku, Tokyo, Japan
Local Institution - 0129, Minato-ku, Tokyo, Japan
Local Institution - 0114, Osaka, Japan
Local Institution - 0052, Amsterdam, Netherlands
Local Institution - 0051, Amsterdam, Netherlands
Local Institution - 0050, Utrecht, Netherlands
Local Institution - 0033, Bergen, Norway
Local Institution - 0034, Lorenskog, Norway
Local Institution - 0035, Oslo, Norway
Pan American Center for Oncology Trials, LLC, Rio Piedras, Puerto Rico
Local Institution - 0076, Cluj-Napoca, Cluj, Romania
Local Institution - 0168, Brasov, Romania
Local Institution - 0080, Bucharest, Romania
Local Institution, Constanta, Romania
Local Institution - 0081, Craiova, Romania
Local Institution - 0205, Iași, Romania
Local Institution - 0089, Suceava, Romania
Local Institution - 0173, A Coruna, Spain
Local Institution - 0056, Badalona-barcelona, Spain
Local Institution - 0006, Barcelona, Spain
Local Institution, Madrid, Spain
Local Institution - 0005, Madrid, Spain
Local Institution - 0172, Malaga, Spain
Local Institution - 0063, Sevilla, Spain
Local Institution - 0171, Valencia, Spain
Local Institution - 0092, Adana, Turkey
Local Institution - 0101, Istanbul, Turkey
Local Institution, London, Greater London, United Kingdom
Local Institution, Leeds, Yorkshire, United Kingdom
Local Institution - 0127, London, United Kingdom
Local Institution - 0049, Oxford, United Kingdom
Preoperative Valproic Acid and Radiation Therapy for Rectal Cancer
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT01898104
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1, Fase 2
Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008)
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04895722
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 0802), Milan, Lombardia, Italy
Istituto Oncologico Veneto IRCCS ( Site 0804), Padova, Veneto, Italy
Istituto Nazionale Tumori IRCCS Fondazione Pascale-Department of Abdominal Oncology ( Site 0803), Napoli, Italy
Mid Florida Cancer Center ( Site 1519), Orange City, Florida, United States
University Cancer & Blood Center, LLC ( Site 1521), Athens, Georgia, United States
University of Chicago Medical Center-Medicine - Section of Hematology/Oncology - Gastrointestinal P, Chicago, Illinois, United States
Icahn School of Medicine at Mount Sinai ( Site 1528), New York, New York, United States
Hematology Oncology Associates of Rockland ( Site 1525), Nyack, New York, United States
UPMC Hillman Cancer Center ( Site 1516), Pittsburgh, Pennsylvania, United States
Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 1509), Nashville, Tennessee, United States
UT Southwestern Medical Center ( Site 1551), Dallas, Texas, United States
Baylor Scott & White Medical Center - Temple-Division of Hematology/Oncology ( Site 1549), Temple, Texas, United States
Northwest Medical Specialties, PLLC ( Site 1546), Tacoma, Washington, United States
UZ Brussel ( Site 0105), Brussels, Bruxelles-Capitale, Region De, Belgium
Université Catholique de Louvain-Namur - Centre Hospitalier -Oncology ( Site 0102), Yvoir, Namur, Belgium
UZ Leuven ( Site 0101), Leuven, Vlaams-Brabant, Belgium
The Moncton Hospital-Oncology ( Site 0307), Moncton, New Brunswick, Canada
McGill University Health Centre-CIM - Oncology ( Site 0306), Montréal, Quebec, Canada
Assistance Publique Hôpitaux de Marseille - Hôpital de la Ti-Service d'Hepato-Gastro-Enterologie et, Marseille, Bouches-du-Rhone, France
Centre Georges François Leclerc ( Site 0506), Dijon, Cote-d Or, France
CHU Rangueil-Digestive oncology department ( Site 0502), Toulouse, Haute-Garonne, France
Hopital Claude Huriez - CHU de Lille ( Site 0510), Lille, Nord, France
Centre Hospitalier Universitaire de Poitiers ( Site 0511), Poitiers, Vienne, France
Hôpital Saint Antoine-Oncologie médicale ( Site 0508), Paris, France
Universitaetsklinikum Carl Gustav Carus Dresden-Medical Dept I - Medical Oncology ( Site 0601), Dresden, Sachsen, Germany
Charité Universitaetsmedizin Berlin - Campus Mitte ( Site 0604), Berlin, Germany
Asklepios Altona-Oncology ( Site 0602), Hamburg, Germany
Kyungpook National University Chilgok Hospital-Hematology/oncology ( Site 1103), Daegu, Taegu-Kwangyokshi, Korea, Republic of
Korea University Anam Hospital ( Site 1107), Seoul, Korea, Republic of
Seoul National University Hospital-Internal Medicine ( Site 1101), Seoul, Korea, Republic of
Severance Hospital, Yonsei University Health System-Medical oncology ( Site 1104), Seoul, Korea, Republic of
Asan Medical Center-Department of Oncology ( Site 1105), Seoul, Korea, Republic of
Samsung Medical Center-Division of Hematology/Oncology ( Site 1102), Seoul, Korea, Republic of
The Catholic Univ. of Korea Seoul St. Mary's Hospital-Medical Oncology ( Site 1106), Seoul, Korea, Republic of
DOLNOSLASKIE CENTRUM ONKOLOGII PULMONOLOGII I HEMATOLOGII ( Site 0920), Wroclaw, Dolnoslaskie, Poland
Powiatowe Centrum Zdrowia ( Site 0911), Brzeziny, Lodzkie, Poland
Luxmed Onkologia sp. z o. o. ( Site 0915), Warszawa, Mazowieckie, Poland
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Onkologii i Radioterapii ( Site, Warszawa, Mazowieckie, Poland
Mrukmed-Mrukmed ( Site 0901), Rzeszow, Podkarpackie, Poland
Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie-Oddzial Dzienny Chemioterapii ( Site 0903), Koszalin, Zachodniopomorskie, Poland
Saint-Petersburg City Clinical Oncology Dispensary-Department of chemotherapy ( Site 1001), Saint Petersburg, Leningradskaya Oblast, Russian Federation
Fed State Budgetary Inst N.N. Blokhin Med Center of Oncology-Clinical Pharmacology and Chemotherapy, Moscow, Moskva, Russian Federation
First Moscow State Medical University I.M. Sechenov-Interhospital Institution Health Management Cl, Moscow, Moskva, Russian Federation
Rostov Cancer Research Institute ( Site 1014), Rostov on Don, Rostovskaya Oblast, Russian Federation
GBUZ SPb CRPCstmc(o) ( Site 1005), Sankt- Peterburg, Sankt-Peterburg, Russian Federation
Republican Clinical Oncology Dispensary-Chemotherapy #3 ( Site 1006), Kazan, Tatarstan, Respublika, Russian Federation
Hospital Universitario Central de Asturias-Medical Oncology ( Site 1203), Oviedo, Asturias, Spain
Hospital Universitario Marqués de Valdecilla ( Site 1202), Santander, Cantabria, Spain
HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON ( Site 1206), Madrid, Madrid, Comunidad De, Spain
H.R.U Málaga - Hospital General ( Site 1207), Málaga, Malaga, Spain
Hospital Universitari Vall d'Hebron ( Site 1201), Barcelona, Spain
Hospital Clinico San Carlos-Oncology Department ( Site 1204), Madrid, Spain
Baskent University Dr. Turgut Noyan Research and Training Center ( Site 1303), Adana, Turkey
Hacettepe Universitesi-oncology hospital ( Site 1301), Ankara, Turkey
Ankara City Hospital-Medical Oncology ( Site 1306), Ankara, Turkey
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1305), Istanbul, Turkey
Beatson West of Scotland Cancer Centre-Clinical Trials Unit ( Site 1401), Glasgow, Glasgow City, United Kingdom
UCLH-Cancer Clinical Trials Unit ( Site 1402), London-Camden, London, City Of, United Kingdom
Velindre Cancer Centre-Research and Development ( Site 1415), Cardiff, United Kingdom
University Hospital Coventry & Warwickshire ( Site 1406), Coventry, United Kingdom
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04449874
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1
Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori IRST - PPDS, Meldola, Emilia-Romagna, Italy
Irccs Ospedale San Raffaele;Oncologia Medica, Milano, Lombardia, Italy
Asst Grande Ospedale Metropolitano Niguarda, Milano, Lombardia, Italy
Istituto Clinico Humanitas, Rozzano (MI), Lombardia, Italy
Azienda Ospedaliero Universitaria Pisana, Pisa, Toscana, Italy
City of Hope Comprehensive Cancer Center, Duarte, California, United States
UCSD Moores Cancer Center, La Jolla, California, United States
Chao Family Comprehensive Cancer Center UCI, Orange, California, United States
Univ of Calif, San Francisco; Breast Cancer Center, San Francisco, California, United States
Yale Cancer Center, New Haven, Connecticut, United States
Florida Cancer Specialists - Sarasota, Sarasota, Florida, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
University of Oklahoma; Stephenson Oklahoma Canc Ctr, Oklahoma City, Oklahoma, United States
Abramson Cancer Center; Univ of Pennsylvania, Philadelphia, Pennsylvania, United States
UPMC - Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia
Alfred Health, Melbourne, Victoria, Australia
Peter MacCallum Cancer Center, North Melbourne, Victoria, Australia
Linear Clinical Research Limited, Nedlands, Western Australia, Australia
UZ Antwerpen, Edegem, Belgium
CHU de Liège, Liège, Belgium
AZ St Maarten Campus Leopoldstr, Mechelen, Belgium
Santa Casa de Misericórdia de Belo Horizonte - PPDS, Belo Horizonte, MG, Brazil
Hospital de Clinicas de Porto Alegre (HCPA) - PPDS, Porto Alegre, PA, Brazil
Hospital Erasto Gaertner, Curitiba, PR, Brazil
Instituto Nacional de Câncer, Rio de Janeiro, RJ, Brazil
Universidade de Caxias do Sul, Caxias Do Sul, RS, Brazil
Hospital Sao Lucas Da Pontificia Universidade Catolica Do Rio Grande Do Sul (PUCRS), Porto Alegre, RS, Brazil
Hospital de Cancer de Barretos, Barretos, SP, Brazil
Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Hospital de Base - PPDS, Sao Jose Do Rio Preto, SP, Brazil
Ottawa Hospital, Ottawa, Ontario, Canada
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Jewish General Hospital; Sir Mortimer B. Davis, Montreal, Quebec, Canada
Clinexpert Kft. - Gyongyos, Gyongyos, Hungary
Rambam Medical Center, Haifa, Israel
Sheba Medical Center - PPDS, Ramat-Gan, Israel
Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
Aga Khan University Hospital, Nairobi, Kenya
Seoul National University Bundang Hospital, Seongnam-si, Korea, Republic of
Seoul National University Hospital, Seoul, Korea, Republic of
Asan Medical Center - PPDS, Seoul, Korea, Republic of
Samsung Medical Center - PPDS, Seoul, Korea, Republic of
Het Nederlands Kanker Instituut Antoni Van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands
Leids Universitair Medisch Centrum, Leiden, Netherlands
Maastricht University Medical Center, Maastricht, Netherlands
Universitair Medisch Centrum Utrecht, Utrecht, Netherlands
Auckland City Hospital, Auckland, New Zealand
New Zealand Clinical Research - Christchurch, Christchurch, New Zealand
Haukeland University Hospital; Hospital Pharmacy, Bergen, Norway
Oslo university hospital Radiumhospitalet, Oslo, Norway
Medical University of Gdansk, Gdansk, Poland
Biokinetica, Przychodnia Jozefow, Jozefow, Poland
Uniwersytecki Szpital Kliniczny w Poznaniu, Pozna?, Poland
Republican Clinical Oncology Dispensary of Ministry of Healthcare of Tatarstan Republic, Kazan, Tatarstan, Russian Federation
Hospital Universitari Vall d'Hebron, Barcelona, Spain
START Madrid-FJD, Hospital Fundacion Jimenez Diaz, Madrid, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Hospital Universitario HM Sanchinarro-CIOCC, Madrid, Spain
Hospital Clinico Universitario Virgen de la Victoria, Malaga, Spain
Hospital Universitario Virgen del Rocío, Sevilla, Spain
Hospital Clinico Universitario de Valencia, Valencia, Spain
Universitaetsspital Basel; Onkologie, Basel, Switzerland
Inselspital, Bern, Switzerland
Hôpitaux Universitaires de Genève, Genève, Switzerland
Unversitätsspital Zürich, Zürich, Switzerland
Velindre Cancer Centre, Cardiff, United Kingdom
University College London Hospitals NHS Foundation Trust; NIHR UCLH Clinical Research Facility, London, United Kingdom
The Christie NHS Foundation Trust, Manchester, United Kingdom
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03362177
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 3
Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Italy
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milano, Italy
Azienda Ospedaliera Citta della Salute e della Scienza di Torino Ospedale Molinette, Torino, Italy
Saint Bernards Medical Center, Jonesboro, Arkansas, United States
Pacific Cancer Medical Center Inc, Anaheim, California, United States
University of California Irvine, Orange, California, United States
Colorado West Healthcare System dba Grand Valley Oncology, Grand Junction, Colorado, United States
Mid Florida Hematology and Oncology Centers PA, Orange City, Florida, United States
Oncology and Hematology Associates of West Broward, PA, Tamarac, Florida, United States
Cleveland Clinic Florida, Weston, Florida, United States
Orchard Healthcare Research Inc, Skokie, Illinois, United States
Christus Saint Frances Cabrini Hospital, Alexandria, Louisiana, United States
University Medical Center New Orleans, New Orleans, Louisiana, United States
CHRISTUS Highland Cancer Treatment Center, Shreveport, Louisiana, United States
Mercy Medical Center, Baltimore, Maryland, United States
American Oncology Partners of Maryland, PA, Bethesda, Maryland, United States
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Hattiesburg Clinic Hematology/Oncology, Hattiesburg, Mississippi, United States
Oncology Hematology Associates, Springfield, Missouri, United States
Morristown Medical Center, Morristown, New Jersey, United States
Regional Cancer Care Associates, Sparta, New Jersey, United States
The Center for Cancer and Blood Disorders, Fort Worth, Texas, United States
Medical Oncology Associates PS, Spokane, Washington, United States
Yakima Valley Memorial Hospital, Yakima, Washington, United States
Hospital Universitario Fundacion Favaloro, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Instituto Oncologico Cordoba, Cordoba, Córdoba, Argentina
Centro de Investigaciones Clínicas Clínica Viedma, Viedma, Río Negro, Argentina
Centro de Diagnostico Investigacion y Tratamiento, Salta, Argentina
Landeskrankenhaus Steyr, Steyr, Austria
Universitaetsklinikum Allgemeines Krankenhaus Wien, Wien, Austria
Instituto de Oncologia do Parana, Curitiba, Paraná, Brazil
Vencer e Oncoclinica, Teresina, Piauí, Brazil
Centro de Pesquisa da Serra Gaucha - Cepesg, Caxias do Sul, Rio Grande Do Sul, Brazil
Catarina Pesquisa Clinica, Itajaí, Santa Catarina, Brazil
Loema Instituto de Pesquisa Clinica & Consultores Ltda, Campinas, São Paulo, Brazil
Casa de Saude Santa Marcelina, Sao Paulo, São Paulo, Brazil
Complex Oncology Center - Ruse EOOD, Ruse, Bulgaria
Medical Center Nadezhda Clinical EOOD, Sofia, Bulgaria
Specialized Hospital for Active Treatment of Oncology EAD, Sofia, Bulgaria
Cape Breton Cancer Centre, Nova Scotia Health Authority, Sydney, Nova Scotia, Canada
Grand River Regional Cancer Centre at Grand River Hospital, Kitchener, Ontario, Canada
Fundacion Colombiana de Cancerologia Clinica Vida, Medellin, Antioquia, Colombia
Oncomedica Imat, Monteria, Córdoba, Colombia
Centro Medico Imbanaco, Cali, Valle Del Cauca, Colombia
Centre Hospitalier Universitaire de Brest, Brest cedex, France
Hôpital Européen Georges Pompidou, Paris, France
Hopital Foch, Suresnes, France
Institut Gustave Roussy, Villejuif Cedex, France
General Hospital of Athens Laiko, Athens, Greece
Aretaieio Hospital, Athens, Greece
Evgenidio Hospital I Agia Trias, Athens, Greece
Attikon University Hospital, Athens, Greece
General Oncology Hospital of Kifissia Agioi Anargyroi, Athens, Greece
University Hospital of Patras, Patra, Greece
Agios Loukas Clinic, Thessaloniki, Greece
Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet, Budapest, Hungary
Debreceni Egyetem Klinikai Kozpont, Debrecen, Hungary
Petz Aladar Egyetemi Oktato Korhaz, Gyor, Hungary
Szegedi Tudomanyegyetem Altalanos Orvostudomanyi Kar Szent Gyorgyi Albert Klinikai Kozpont, Szeged, Hungary
Oncotech, La Paz, Baja California Sur, Mexico
Centro de Atencion e Investigacion Cardiovascular del Potosi Sc, San Luis Potosi, San Luis Potosí, Mexico
Centro Medico Nacional Siglo XXI, Mexico, Mexico
Oaxaca Site Management Organization SC, Oaxaca, Mexico
Hospital Goyeneche, Arequipa, Peru
Oncosalud, Lima, Peru
Wojewodzki Szpital Specjalistyczny w Bialej Podlaskiej, Biala Podlaska, Poland
Powiatowe Centrum Zdrowia w Brzezinach Sp Z o o, Brzeziny, Poland
Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan, Poland
Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan, Poland
Centro Hospitalar de Lisboa Norte, EPE - Hospital de Santa Maria, Lisboa, Portugal
Unidade Local de Saude de Matosinhos, EPE - Hospital Pedro Hispano, Matosinhos, Portugal
Centro Hospitalar Universitario do Porto EPE - Hospital de Santo Antonio, Porto, Portugal
Centro Hospitalar Universitario de Sao Joao, EPE - Hospital Sao Joao, Porto, Portugal
Centro Hospitalar Tras-os-Montes e Alto Douro EPE - Unidade de Vila Real, Vila Real, Portugal
Policlinica de Diagnostic Rapid, Brasov, Romania
Fundeni Clinical Institute for Digestive Disorders and Liver Transplantation, Bucharest, Romania
Spitalul Clinic al Cailor Ferate Cluj Napoca, Cluj-Napoca, Romania
SC Medisprof SRL, Cluj-Napoca, Romania
Centrul de Oncologie Sf Nectarie SRL, Craiova, Romania
Institutul Regional de Oncologie Iasi, Iasi, Romania
SC Oncomed SRL, Timisoara, Romania
SBHI of Arkhangelsk region Arkhangelsk clinical oncology dispensary, Arkhangelsk, Russian Federation
Autonomic SHI Republican clinical oncology dispensary of MoH of the Republic of Tatarstan, Kazan, Russian Federation
Medsi Group, Moscow Region, Russian Federation
Clinical hospital 2, Group of companies medsi, Moscow, Russian Federation
LLC Tonus, Nizhniy Novgorod, Russian Federation
Omsk Regional Clinical Oncology Dispensary, Omsk, Russian Federation
State budget institution of public health Pyatigorsk oncology dispensary, Pyatigorsk, Russian Federation
State Institution of Public Health, Ryazan, Russian Federation
Leningrad Regional Oncology Dispensary na L D Roman, Saint Petersburg, Russian Federation
FSBI Scientific and Research Oncology Institute named after N N Petrov, Saint-Petersburg, Russian Federation
State Institution of Public Health Oncology Dispensary 2 of Public Health Krasnodar Region, Sochi, Russian Federation
State Institution of Public Health Tambov Regional Oncology Dispensary, Tambov, Russian Federation
Respublican clinical oncology dispensary Minzdrava of Republic of Bashkortostan, Ufa, Russian Federation
Hospital Clinico Universitario San Cecilio, Granada, Andalucía, Spain
Hospital Clinico Universitario de Salamanca, Salamanca, Castilla León, Spain
Hospital Universitario Arnau de Vilanova Lleida, Lleida, Cataluña, Spain
Hospital Universitari Sant Joan de Reus, Reus, Cataluña, Spain
Complexo Hospitalario Universitario de Ourense, Ourense, Galicia, Spain
Hospital Universitario Madrid Sanchinarro, Madrid, Spain
Baskent Universitesi Adana Doktor Turgut Noyan Uygulama ve Arastirma Merkezi, Adana, Turkey
Doktor Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi, Ankara, Turkey
Hacettepe Universitesi Tip Fakultesi, Ankara, Turkey
Gazi Universitesi Saglik Arastirma ve Uygulama Merkezi Gazi Hastanesi, Ankara, Turkey
Ankara Sehir Hastanesi, Ankara, Turkey
Trakya Universitesi Saglik Arastirma ve Uygulama Merkezi, Edirne, Turkey
Istanbul Universitesi Onkoloji Enstitusu, Istanbul, Turkey
Prof Dr Cemil Tascioglu Sehir Hastanesi, Istanbul, Turkey
Goztepe Prof Dr Suleyman Yalcin Sehir Hastanesi, Istanbul, Turkey
Ege Universitesi Tip Fakultesi, Izmir, Turkey
Medical Point Izmir Hastanesi, Izmir, Turkey
Kocaeli Universitesi Arastirma ve Uygulama Hastanesi, Kocaeli, Turkey
VM Medical Park Samsun Hastanesi, Samsun, Turkey
Communal Institution Chernivtsi Regional Clinical Oncological Dispensary, Chernivtsi, Ukraine
Prykarpatskyy Clinical Oncology Centre, Ivano-Frankivsk, Ukraine
Transcarpathian Regional Clinical Oncological Dispensary, Uzhgorod, Ukraine
Artificial Intelligence for Leaving in Situ Colorectal Polyps.
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05500248
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Non Disponibile
Registry of Subjects at Risk of Pancreatic Cancer
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04095195
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Istituto Clinico Humanitas, Rozzano, Milan, Italy
Ospedale Pederzoli, Peschiera Del Garda, Verona, Italy
San Raffele Vita Salute University Hospital, Milano, Italy
Chirurgia Generale e del Pancreas, Verona, Italy
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
- Stato: In arruolamento
- Fascia d'età:
- Codice Sperimentazione: NCT05732623
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Prof Giulia Martina Cavestro, MD PhD, Milan, Lombardy, Italy
Department of Medicine-Gastroenterology, Denver Veterans Affairs Medical Center, University of Colorado Hospital, Denver, Colorado, United States
Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine University of Chicago Medicine, Chicago, Illinois, United States
Department of Gastrointestinal Surgery, Helsinki University Hospital, Helsinki, Finland
Department of General, Visceral and Transplant Surgery, Hospital of the University of Munich (LMU), Munich, Germany
Gabriela Moslein, Wuppertal, Germany
Division of Cancer Medicine, Oslo University Hospital (OUS), Institute for Cancer Genetics and Informatics Norwegian Radium Hospital, Oslo, Norway
Department of Gastroenterology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain
Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05358249
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1, Fase 2
Novartis Investigative Site, Milano, MI, Italy
Massachusetts General Hospital, Boston, Massachusetts, United States
Dana Farber Cancer Institute Dept.of DFCI, Boston, Massachusetts, United States
Novartis Investigative Site, Leuven, Belgium
Novartis Investigative Site, Bordeaux, France
Novartis Investigative Site, Seoul, Korea, Republic of
Novartis Investigative Site, Singapore, Singapore
Novartis Investigative Site, Madrid, Spain
Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal Cancer
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT01651026
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
A.O.R.N. V. Monaldi, Napoli, Italy
A.O.U. Federico II, Napoli, Italy
Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento Entero-proctologico, Napoli, Italy
Transanal Reinforcement of Low Rectal Anastomosis in Rectal Cancer Surgery
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT02279771
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Non Disponibile
Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal Cancer
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05136326
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Radiologic Assessment in Complete Mesocolic Excision for Right Colon Cancer (RACOMERC)
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04834011
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Azienda Ospedaliera Universitaria Policlinico "P. Giaccone" Palermo - University of Palermo, Palermo, Italy - Sicily, Italy
Capecitabine Plus Concomitant Radiation Therapy Followed by Durvalumab as Preoperative Treatment in Rectal Cancer
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04083365
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05253846
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
U.O. Oncologia Medica 2 Universitaria - Azienda Ospedaliero-Universitaria Pisana Dipartimento di Ricerca Traslazionale e Nuove Tecnologie - University of Pisa, Pisa, Italy
BReak Interval Delayed Surgery for Gastrointestinal Extraperitoneal Rectal Cancer
- Stato: In arruolamento
- Fascia d'età: Bambini, AdultiAnziani
- Codice Sperimentazione: NCT03581344
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Non Disponibile
Urinary and Sexual Dysfunctions Evaluation After Rectal Resection
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04404673
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Fondazione Policlinico Universitario Agostino Gemelli IRCCS di Roma, Roma, Lazio, Italy
Timisnar - Biomarkers Substudy (Timisnar-mirna)
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03962088
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Endoscopic Resection of Gastrointestinal Neoplasms
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04780256
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
IMMUNOlogical Microenvironment in REctal Adenocarcinoma Treatment.
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04917263
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
IMMUNOlogical Microenvironment in REctal Adenocarcinoma Treatment
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04915326
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Assessing the Additional Neoplasia Yield of Computer-aided Colonoscopy in a Screening Setting
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04441580
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Non Disponibile
Establishment of a Tumor Bank for Blood Samples
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT01763125
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
European Institute of Oncology, Division of Gynecologic Oncology, Unit of Preventive Gynecology, Milan, Italy
Innsbruck Medical University, Innsbruck, Austria
University Hospitals Leuven - Department of Obstetrics and Gynaecology, Leuven, Belgium
Charité University - Campus Virchow Chlinic, Berlin, Germany
University Medical Center Freiburg, Freiburg, Germany
University Clinic of Ruhr University Bochum, Herne, Germany
Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03803436
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
SOD Clinica di Chirurgia Epatobiliare, Pancreatica e dei Trapianti e SC di Oncologia Medica, Ospedali Riuniti di Ancona, Ancona, Italy
ASST Papa Giovanni XXIII, Bergamo, Italy
Chirurgia EBP e dei Trapianti di Fegato e SC di Oncologia Medica, Ospedale Policlinico San Martino, Genova, Italy
Ospedale Maggiore di Milano Policlinico, Milano, Italy
Azienda Ospedaliera Ospedale Niguarda Ca' Granda, Milano, Italy
Fondazione IRCCS Istituto NAzionale Tumori di Milano, Milan, Italy
Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT), Palermo, Italy
GONO Group (Gruppo Oncologico Nord Ovest) TRIPLETE Trial Coordination, Pisa, Italy
Fondazione Policlinico Universitario A.Gemelli IRCCS, Roma, Italy
Ospedale Universitario Molinette S. Giovanni Battista di Torino, Torino, Italy
Centro Trapianti di Fegato e SC di Oncologia Medica, A.S.U. Integrata di Udine, Udine, Italy
Centro Trapianti di Fegato e SC di Oncologia Medica, A.O.U. Integrata di Verona, Verona, Italy
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04920149
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Dept. of Scientific Medicine and Surgery, University of Bologna, Bologna, Emilia-Romagna, Italy
Hvidovre Hospital, Hvidovre, Denmark
Department of Genetics and Pathomorphology of Pomeranian Medical University, Szczecin, Poland
Sahlgrenska University Hsospital, Göteborg, Gothenburg, Sweden
Skåne University Hospital, Malmö, Skåne, Sweden
Karolinska University Hospital, Stockholm, Sweden
Norrland University Hospital, Umeå, Sweden
Akademiska hospital, Uppsala, Sweden
Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04959448
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Istituto Clinico Humanitas, Rozzano, Milano, Italy
Azienda Ospedaliero Universitara Policlinico di Catania, Catania, Sicily, Italy
Universita Degli Studi di Pisa Ospedale di Cisanello Pisa, Pisa, Toscana, Italy
Azienda Ospedaliero Universitaria Senese, Siena, Toscana, Italy
Fondazione universitaria Policlinico A. Gemelli, Rome, Italy
Azienda Ospedaliero Universitaria di Sassari, Sassari, Italy
Excel ENT of Alabama, Birmingham, Alabama, United States
Medical Research of Arizona, a division of Allergy, Asthma & Immunology Associates, Scottsdale, Arizona, United States
The Allergy and Rheumatology Medical Clinic, La Jolla, California, United States
ARK Clinical Research, Long Beach, California, United States
Sacramento Ear, Nose & Throat, Roseville, California, United States
Breathe Clear Institute, Torrance, California, United States
Allergy & Asthma Clinical Research, Walnut Creek, California, United States
AADRS Clincial Research Center, Coral Gables, Florida, United States
University of Florida, Gainesville, Florida, United States
Damask Physicians Group, Lake Mary, Florida, United States
University of South Florida, Tampa, Florida, United States
Emory University Hospital Midtown, Atlanta, Georgia, United States
IACT Health, Columbus, Georgia, United States
Treasure Valley Medical Research, Boise, Idaho, United States
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
The University of Chicago Medical Center UCMC Duchossois Center for Advanced Medicine DCAM, Chicago, Illinois, United States
Asthma & Allergy Center of Chicago, Oak Park, Illinois, United States
Brigham & Women's Hospital, Boston, Massachusetts, United States
University of Michigan, Michigan Medicine Pulmonary Clinic, Ann Arbor, Michigan, United States
Allergy & Asthma Center of Minnesota - Allergology, Maplewood, Minnesota, United States
University of Missouri, Columbia, Missouri, United States
University of Nebraska Medical Center, Omaha, Nebraska, United States
Atlantic Research Center LLC, Ocean City, New Jersey, United States
Northwell Health, Great Neck, New York, United States
Montefiore Medical Center, New York, New York, United States
Rochester Regional Health System, Rochester, New York, United States
University of Rochester Medical Center, Rochester, New York, United States
Duke University Medical Center, Durham, North Carolina, United States
Allergy Partners of the Triangle, Raleigh, North Carolina, United States
Wake Forest Baptist Health, Winston-Salem, North Carolina, United States
University of Cincinnati College of Medicine, Cincinnati, Ohio, United States
Essential Medical Research, Tulsa, Oklahoma, United States
Asthma, Nasal Disease & Allergy Research Center of New England, East Providence, Rhode Island, United States
Allergy and Asthma Physicians of RI, Lincoln, Rhode Island, United States
Medical University Of South Carolina, Charleston, South Carolina, United States
ADAC research, PA, Greenville, South Carolina, United States
Spartanburg Ear, Nose & Throat Clinical, Spartanburg, South Carolina, United States
ENT & Allergy Partners, Summerville, South Carolina, United States
Vanderbilt University Medical Center, Nashville, Tennessee, United States
STAAMP Research, San Antonio, Texas, United States
Tanner Clinic, Layton, Utah, United States
University of Virginia Health System (UVA), Charlottesville, Virginia, United States
Eastern Virginia Medical School, Norfolk, Virginia, United States
Richmond Ear Nose & Throat, Richmond, Virginia, United States
The Vancouver Clinic, Vancouver, Washington, United States
Dr. Richard Gall Med Corp, Winnipeg, Manitoba, Canada
Gordon Sussman Clinical Research, Toronto, Ontario, Canada
Toronto Allergy & Asthma Clinic-Pulmonology, Toronto, Ontario, Canada
Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada
Hopital Du Saint-Sacrement, Quebec, Canada
University Hospital Mannheim - Dermatology, Venerology, Allergology, Mannheim, Baden-Württemberg, Germany
Oberhavelkliniken Hennigsdorf, Hennigsdorf, Brandenburg, Germany
Zentrum für Rhinologie, Wiesbaden, Hessen, Germany
Universitätsklinikum Jena, Jena, Thüringen, Germany
University of Fukui Hospital - Otorhinolaryngology, Yoshida-gun, Hukui, Japan
Fujisawa City Hospital, Fujisawa, Kanagawa, Japan
Nagaoka Red Cross Hospital - Otorhinolaryngology, Nagaoka, Niigita, Japan
Osaka Haibikino Medical Center, Habikino, Osaka, Japan
Tokyo Kyosai Hospital, Meguro-Ku, Tokyo, Japan
Matsuwaki Clinic Shinagawa, Shinagawa-Ku, Tokyo, Japan
Kyoto Nose & Allergy Clinic, Kyoto, Japan
A Study of SGN-STNV in Advanced Solid Tumors
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04665921
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1
Istituto Europeo di Oncologia, Milan, Other, Italy
The Angeles Clinic and Research Institute, Los Angeles, California, United States
University of California at San Francisco, San Francisco, California, United States
Shands Cancer Center / University of Florida, Gainesville, Florida, United States
University of Miami, Miami, Florida, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
South Texas Accelerated Research Therapeutics Midwest, Grand Rapids, Michigan, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Case Western Reserve University / University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
Oregon Health and Science University, Portland, Oregon, United States
Magee Womens Hospital of UPMC, Pittsburgh, Pennsylvania, United States
South Texas Accelerated Research Therapeutics, San Antonio, Texas, United States
University of Ottawa / Ottawa General Hospital, Ottawa, Ontario, Canada
University Health Network, Princess Margaret Hospital, Toronto, Other, Canada
Institut Gustave Roussy, Villejuif Cedex, Other, France
Hospital Universitario Vall d'Hebron, Barcelona, Other, Spain
The Royal Marsden Hospital (Surrey), Sutton, Other, United Kingdom
Liver Transplantation for Non-Resectable Colorectal Liver Metastasis
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05185245
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Non Disponibile
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04699188
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1, Fase 2
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Milano, MI, Italy
Emory University School of Medicine/Winship Cancer Institute Winship Cancer Center, Atlanta, Georgia, United States
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Washington University School of Medicine, Saint Louis, Missouri, United States
Providence Cancer Center, Portland, Oregon, United States
Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
University of Texas MD Anderson Cancer Center Dept of MD Anderson CancerCent, Houston, Texas, United States
Novartis Investigative Site, Melbourne, Victoria, Australia
Novartis Investigative Site, Leuven, Belgium
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Guangzhou, Guangdong, China
Novartis Investigative Site, Beijing, China
Novartis Investigative Site, Copenhagen, Denmark
Novartis Investigative Site, Lyon Cedex, France
Novartis Investigative Site, Villejuif Cedex, France
Novartis Investigative Site, Dresden, Germany
Novartis Investigative Site, Essen, Germany
Novartis Investigative Site, Freiburg, Germany
Novartis Investigative Site, Koeln, Germany
Novartis Investigative Site, Hong Kong, Hong Kong
Novartis Investigative Site, Nagoya, Aichi, Japan
Novartis Investigative Site, Yokohama-city, Kanagawa, Japan
Novartis Investigative Site, Chuo ku, Tokyo, Japan
Novartis Investigative Site, Koto ku, Tokyo, Japan
Novartis Investigative Site, Osaka, Japan
Novartis Investigative Site, Seoul, Korea, Republic of
Novartis Investigative Site, Amsterdam, Netherlands
Novartis Investigative Site, Singapore, Singapore
Novartis Investigative Site, Singapore, Singapore
Novartis Investigative Site, Barcelona, Catalunya, Spain
Novartis Investigative Site, Valencia, Comunidad Valenciana, Spain
Novartis Investigative Site, Madrid, Spain
Novartis Investigative Site, Taipei, Taiwan
LDLT in Non Resectable Colo-rectal Cancer Liver Metastasis
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05186116
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Non Disponibile
Colorectal Metastasis and Liver Transplantation With Organs From Deceased Donors
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04870879
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Non Disponibile
U.O.C Chirurgia Epatobiliare e Trapianti Epatici, Azienda Ospedaliera di Padova, Padova, Italy
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04895709
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1, Fase 2
Humanitas, Rozzano, Milano, Italy
Local Institution - 0033, Candiolo, Torino, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1, Milan, Italy
Local Institution - 0034, Napoli, Italy
Local Institution - 0040, Roma, Italy
ospedale le scotte-U.O.C. Immunoterapia Oncologica, Siena, Italy
Community Cancer Institute, Clovis, California, United States
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
John Theurer Cancer Center, Hackensack, New Jersey, United States
Columbia University Medical Center-CUIMC Herbert Irving Comprehensive Cancer Center Clinical Protoco, New York, New York, United States
Memorial Sloan Kettering Nassau, New York, New York, United States
Providence Cancer Center Oncology and Hematology Care- Eastside, Portland, Oregon, United States
Local Institution - 0057, Blacktown, New South Wales, Australia
Local Institution - 0058, Liverpool, New South Wales, Australia
Local Institution - 0054, Brisbane, Queensland, Australia
Local Institution - 0053, Malvern, Victoria, Australia
Local Institution - 0055, Melbourne, Victoria, Australia
Local Institution - 0056, Nedlands, Western Australia, Australia
Local Institution, Edmonton, Alberta, Canada
Local Institution - 0029, Hamilton, Ontario, Canada
Local Institution - 0009, Toronto, Ontario, Canada
Local Institution - 0015, Montreal, Quebec, Canada
Local Institution - 0016, Ottawa, Canada
Local Institution - 0010, Dresden, Germany
Local Institution, Essen, Germany
Local Institution, Frankfurt, Germany
Local Institution - 0044, Ulm, Germany
Local Institution - 0019, Wuerzburg, Germany
Local Institution - 0035, Ramat Gan, HaMerkaz, Israel
Local Institution - 0038, Ramat Gan, HaMerkaz, Israel
Local Institution - 0039, Haifa, HaTsafon, Israel
Local Institution - 0037, Tel Aviv, Tell Abīb, Israel
Local Institution - 0048, Málaga, Andalucía, Spain
Local Institution - 0014, Badalona, Barcelona [Barcelona], Spain
Local Institution - 0049, Barcelona, Barcelona [Barcelona], Spain
Local Institution - 0047, Madrid, Madrid, Comunidad De, Spain
Local Institution - 0013, Madrid, Spain
Local Institution - 0011, Madrid, Spain
Local Institution - 0012, Pamplona, Spain
Timing to Minimally Invasive Surgery After Neoadjuvant Chemoradiotherapy for Rectal Cancer
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03465982
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Non Disponibile
SS. Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, AL, Italy
Ospedale Gian Battista Morgagni - Luigi Pierantoni, Forlì, Forlì-Cesena, Italy
Ospedale Civile Pietro Cosma, Camposampiero, Padua, Italy
Ospedale Sacro Cuore, Negrar, Verona, Italy
Ente Ecclesiastico ospedale generale Regionale Miulli, Acquaviva Delle Fonti, Italy
Ospedale degli Infermi, Biella, Italy
Azienda Ospedaliera Universitaria Careggi, Firenze, Italy
Ospedale Maggiore Policlinico Fondazione Ca' Granda, Milano, Italy
Ospedale San Raffaele IRCCS, Milano, Italy
Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale, Napoli, Italy
Ospedale San Francesco, Nuoro, Italy
Ospedale Sant' Antonio, Padova, Italy
Azienda Ospedaliera San Giovanni - Addolorata, Roma, Italy
Complete Mesocolic Excision in Comparison With Conventional Surgery for the Right Colon Cancer
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04871399
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Non Disponibile
Ospedale della Misericordia, Grosseto, Arezzo, Italy
Ospedale Città di Sesto San Giovanni, Sesto San Giovanni, Milano, Italy
S. Andrea Hospital, La Spezia, Spezia, Italy
Candiolo Cancer Institute - IRCCS, Candiolo, Torino, Italy
Ospedale E. Agnelli Pinerolo, Pinerolo, Torino, Italy
Maggiore Bellaria Hospital, Bologna, Bologna, Italy
Università degli Studi di Ferrara, Ferrara, Italy
Ospedale Policlinico San Martino, Genova, Italy
Azienda Ospedaliera Universitaria Policlinico "G. Martino", Messina, Italy
European Institute of Oncology, Milano, Italy
Federico II University, Napoli, Italy
University of Rome Tor Vergata, Rome, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
University of Turin (AOU.San Luigi Gonzaga), Torino, Italy
Predictors of Disease Recurrence After Curative Surgery for Stage I Colon Cancer
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05726188
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Chirurgia dell'Apparato Digerente, IRCSS Giovanni Paolo II, Bari, Italy
Chirurgia Generale e Trapianto di Fegato, Azienda Ospedaliera Consorziale Policlinico di Bari, Bari, Italy
UO Chirurgia Generale 3, Spedali Civili 1, Brescia, Italy
Chirurgia Coloproctologica, AOU Cagliari, Cagliari, Italy
Chirurgia Generale, Ospedale di Cles, Cles, Italy
Chirurgia 1, Ospedale di Cona, AOUI Ferrara, Cona, Italy
Chirurgia Generale Colorettale, Ospedale degli Infermi, Faenza, Italy
UOS Chirurgia Colo-rettale, Ospedale San Gerardo, Monza, Italy
Chirurgia Endoscopica, AOUI Federico II, Napoli, Italy
UOC Oncologia Chirurgia Colorettale, Istituto Nazionale Tumori - IRCCS Fondazione Pascale, Napoli, Italy
Chirurgia Generale, AOU San Luigi Gonzaga, Orbassano, Italy
Chirurgia Generale 3, AOUI Padova, Padova, Italy
ASL TO 3 Presidio Pinerolo, Chirurgia, Pinerolo, Italy
Chirurgia Generale 2, Policlinico Gemelli, Roma, Italy
Policlinico TOR Vergata, Roma, Chirurgia Mininvasiva e dell'Apparato Digerente, Roma, Italy
UOC Chirurgia Generale 1, Policlinico Gemelli, Roma, Italy
Chirurgia Generale, Ospedale Santa Maria della Misericordia, Rovigo, Italy
Chirurgia Colorettale, IRCCS Humanitas, Rozzano, Italy
Chirurgia d'Urgenza e PS 3, AOU Città della Salute e della Scienza, Torino, Italy
Chirurgia Generale e Mininvasiva, Ospedale San Camillo, Trento, Italy
SC Clinica Chirurgia, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy
Unità di Chirurgia Colorettale, Clinica Santa Rita, Vercelli, Italy
Chirurgia Generale ed Epatobiliare, AOUI Verona, Verona, Italy
Unit of Digestive and HPB Surgery, Henri Mordor University Hospital, Paris, France
Proactive Management of Endoperitoneal Spread in Colonic Cancer
- Stato: Non ancora in arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT02974556
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 3
ASST Nord Milano P.O. Città di Sesto S. Giovanni, Milano, PD, Italy
ASO S. Croce e Carle, Cuneo, Italy
Azienda Ospedaliera dei Colli, Napoli, Italy
Istituto Nazionale Tumori IRCCS Fondazione Pascale di Napoli, Napoli, Italy
Ospedale di Rimini, Rimini, Italy
University of Rome Sapienza, Roma, Italy
Ospedale Sant'Eugenio, Rome, Italy
Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy
A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05256381
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Azienda Socio Sanitaria Territoriale (ASST) degli Spedali Civili di Brescia, Brescia, Italy
Azienda Ospedaliera Universitaria Senese - L'ospedale Santa Maria alle Scotte, Siena, Italy
Innovative Clinical Research Institute, Whittier, California, United States
Cliniques Universitaires Saint-Luc, Brussels, Belgium
Universitair Ziekenhuis Leuven - Campus Gasthuisberg, Leuven, Belgium
Centre Hospitalier Universitaire de Liège, Liège, Belgium
Masarykuv Onkologicky Ustav, Brno, Czechia
Nemocnice Hořovice, Hořovice, Czechia
Fakultní nemocnice Olomouc, Olomouc, Czechia
Gustave Roussy, Villejuif, France
Petz Aladár Egyetemi Oktató Kórház - Győr, Győr, Hungary
Hospital Teresa Herrera - Materno Infantil, A Coruña, Spain
Hospital Universitari Vall d'Hebrón, Barcelona, Spain
Clinica Universidad de Navarra - Pamplona, Madrid, Spain
Clínica Universidad de Navarra - Madrid, Madrid, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Hospital Universitario HM Sanchinarro, Madrid, Spain
Hospital Universitario Puerta de Hierro - Majadahonda, Madrid, Spain
Hospital Clínico Universitario de Valencia, Valencia, Spain
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT02628067
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
MSD Italia S.r.l., Rome, Italy
Call for Information (Investigational Site 0202), Los Angeles, California, United States
Call for Information (Investigational Site 0017), Los Angeles, California, United States
Call for Information (Investigational Site 0010), Boston, Massachusetts, United States
Call for Information (Investigational Site 0008), New Brunswick, New Jersey, United States
Merck Sharp & Dohme, North Ryde, Australia
MSD Brasil, Sao Paulo, Brazil
Merck Canada, Kirkland, Quebec, Canada
MDS Colombia SAS, Bogota, Colombia
Merck Sharp & Dohme, Glostrup, Denmark
MSD France, Paris, France
MSD Sharp & Dohme GmbH, Haar, Germany
Merck Sharp & Dohme Co. Ltd., Hod Hasharon, Israel
MSD Korea LTD, Seoul, Korea, Republic of
MSD, Mexico City, Mexico
Merck Sharp & Dohme BV, Haarlem, Netherlands
MSD Norge A/S, Drammen, Norway
Merck Sharp & Dohme (I.A.) Corporation, Makati, Philippines
Merck Sharp & Dohme IDEA, Inc., Moscow, Russian Federation
MSD (Pty) LTD South Africa, Midrand, South Africa
Merck Sharp and Dohme de Espana S.A., Madrid, Spain
Merck Sharp & Dohme (I.A.) Corp., Taipei, Taiwan
A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)
- Stato: In arruolamento
- Fascia d'età: Bambini, AdultiAnziani
- Codice Sperimentazione: NCT03157128
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1, Fase 2
Istituto Nazionale dei Tumori, Milano, Lombardie, Italy
Mayo Clinic of Scottsdale, Scottsdale, Arizona, United States
City of Hope National Medical Center, Duarte, California, United States
University of California - San Diego, La Jolla, California, United States
UCLA Medical Center, Los Angeles, California, United States
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
Irvine Medical Center, Orange, California, United States
UCSF Medical Center at Mission Bay, San Francisco, California, United States
Kaiser Permanente Santa Clara, Santa Clara, California, United States
Kaiser Permanente Medical Center, Vallejo, California, United States
Sarah Cannon Research Institute at HealthOne, Denver, Colorado, United States
Yale Cancer Center, New Haven, Connecticut, United States
Johns Hopkins University, Washington, District of Columbia, United States
Mayo Clinic in Florida, Jacksonville, Florida, United States
Memorial Hospital Pembroke, Pembroke, Florida, United States
Emory University, Atlanta, Georgia, United States
University of Chicago Medicine-Comprehensive Cancer Center, Chicago, Illinois, United States
Ochsner Clinic Foundation, New Orleans, Louisiana, United States
University of Maryland Medical Center, Baltimore, Maryland, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
University of Michigan, Ann Arbor, Michigan, United States
START Midwest, Grand Rapids, Michigan, United States
Mayo Clinic, Rochester, Minnesota, United States
Washington University Medical School, Saint Louis, Missouri, United States
Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
NYU Langone, New York, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
University of North Carolina, Chapel Hill, North Carolina, United States
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Ohio State University Hospital, Columbus, Ohio, United States
Oregon Health and Science University, Portland, Oregon, United States
University of Pennsylvania Hospital, Philadelphia, Pennsylvania, United States
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Sarah Cannon Research Institute SCRI, Nashville, Tennessee, United States
Vanderbilt University Medical Center, Nashville, Tennessee, United States
University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Virginia Cancer Specialists, PC, Fairfax, Virginia, United States
University of Wisconsin-Madison Hospital and Health Clinic, Madison, Wisconsin, United States
Royal North Shore Hospital, St. Leonards, New South Wales, Australia
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
BC Cancer Vancouver, Vancouver, British Columbia, Canada
Rigshospitalet, Copenhagen, København Ø, Denmark
Hôpital Européen Georges Pompidou, Paris, Cedex 15, France
Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest, Bordeaux, France
Centre Leon Berard, Lyon Cedex 08, France
APHM Hôpital de la Timone, Marseille, France
Institut du Cancer de Montpellier - Val d'aurelle, Montpellier Cedex 5, France
Gustave Roussy, Villejuif Cedex, France
Universitätsklinikum Würzburg A. ö. R., Würzburg, Bayern, Germany
Universitätsklinikum Köln, Köln, Nordrhein-Westfalen, Germany
Prince of Wales Hospital, Hong Kong, Shatin, New Territories, Hong Kong
Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
Shaare Zedek Medical Center, Jerusalem, Yerushalayim, Israel
Soroka Medical Center - Pediatric Outpatient Clinic, Beer-Sheva, Israel
Hadassah Medical Center, Jerusalem, Israel
Nagoya University Hospital, Nagoya, Aichi, Japan
National Cancer Center Hospital East, Kashiwa, Chiba, Japan
Hokkaido University Hospital, Sapporo, Hokkaido, Japan
Hyogo Cancer Center, Akashi, Hyogo, Japan
Kanazawa University Hospital, Kanazawa, Ishikawa, Japan
Kindai University Hospital, Osaka Sayama-shi, Osaka, Japan
Shizuoka Cancer Center, Nagaizumi, Shizuoka, Japan
National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
Japanese Foundation for Cancer Research, Koto, Tokyo, Japan
Tottori University Hospital, Yonago, Tottori, Japan
National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
Okayama University Hospital, Okayama, Japan
Osaka City General Hospital, Osaka, Japan
National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of
Seoul National University Bundang Hospital, Seongnam, Kyǒnggi-do, Korea, Republic of
Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of
Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of
Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of
National Cancer Centre Singapore, Singapore, Singapore
Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona], Spain
Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Hospital Madrid Norte Sanchinarro, Madrid, Spain
Kantonsspital Luzern, Luzern 16, Luzern, Switzerland
Taichung Veterans General Hospital, Taichung, Taiwan
National Taiwan University Hospital, Taipei, Taiwan
Royal Marsden Hospital, Sutton, Surrey, United Kingdom